please go through our product list
| Sr. | Brand Name | Composition | Ph. | Strength | Category | |
| No. | Ref | |||||
| 1 | Methylprednisolone Tablet IP | Each Film Coated Tablet Contains: | glucocorticoids | |||
| Methylprednisolone | IP | 16 mg | ||||
| Excipients | q. s. | |||||
| 2 | Methylprednisolone Tablet IP | Each Film Coated Tablet Contains: | glucocorticoids | |||
| Methylprednisolone | IP | 4 mg | ||||
| Excipients | q. s. | |||||
| 3 | Atorvastatin Tablets IP | Each Film Coated Tablet Contains: | ||||
| Atorvastatin Calcium | IP | 20 mg | HMG-CoA reductase inhibitors (statins) | |||
| eq. to Atorvastatin | ||||||
| Excipients | q. s. | |||||
| 4 | Amlodipine Besylate & Atenolol Tablets | Each Uncoated Tablet Contains: | ||||
| Amlodipine Besylate | beta blockers | |||||
| Eq. to Amlodipine | IP | 5 mg | ||||
| Atenolol | IP | 50 mg | ||||
| Excipients | q. s. | |||||
| 5 | Calcium and vitamin D3 Tablets IP | Each Film Coated Tablet Contains: | ||||
| Calcium Carbonate (from an organic source oyster shell | Food supplement | |||||
| Eq. to elemental calcium | IP | 500 mg | ||||
| Vitamin D3 | IP | 250 IU | ||||
| Excipients | q. s. | |||||
| 6 | Cetrizine Dihydrochloride Tablets IP | Each Film Coated Tablet Contains: | ||||
| Cetrizine Dihydrochloride | IP | 10 mg | antihistamines | |||
| Excipients | q. s. | |||||
| 7 | Deflazacort Tablets | Each Uncoated Tablet Contains: | corticosteroids | |||
| Deflazacort | IP | 6 mg | ||||
| Excipients | q. s. | |||||
| 8 | Methylprednisolone Tablet IP | Each Film Coated Tablet Contains: | glucocorticoids | |||
| Methylprednisolone | IP | 8 mg | ||||
| Excipients | q. s. | |||||
| 9 | Ranitidine Tablet | Each Film Coated Tablet Contains: | H2 antagonist | |||
| Ranitidine Hydrochloride | ||||||
| Eq. to Ranitidine | IP | 150 mg | ||||
| Excipients | q. s. | |||||
| 10 | Ofloxacin & Ornidazole Tablets | Each Film Coated Tablet Contains: | antibiotics | |||
| Ofloxacin | IP | 200 mg | ||||
| Ornidazole | IP | 500 mg | ||||
| Excipients | q. s. | |||||
| 11 | Ciprofloxacin Tablets | Each Film Coated Tablet Contains: | quinolone antibiotics | |||
| Ciprofloxacin hydrochloride | ||||||
| Eq. to Ciprofloxacin | IP | 250 mg | ||||
| Excipients | q. s. | |||||
| 12 | Ofloxacin Tablets | Each Film Coated Tablet Contains: | antibiotics | |||
| Ofloxacin | IP | 400 mg | ||||
| Excipients | q. s. | |||||
| 13 | Fluconazole Tablets | Each Uncoated Tablet Contains: | antifungal | |||
| Fluconazole | IP | 150 mg | ||||
| Excipients | q. s. | |||||
| 14 | Sildenafil Citrate 50 mg Tablets | Each Film Coated Tablet Contains: | erectile dysfunction | |||
| Sildenafil Citrate | IP | 50 mg | ||||
| Excipients | q. s. | |||||
| 15 | Sildenafil Citrate 100 mg Tablets | Each Film Coated Tablet Contains: | erectile dysfunction | |||
| Sildenafil Citrate | IP | 100 mg | ||||
| Excipients | q. s. | |||||
| 16 | Methylprednisolone Tablet IP | Each Uncoated Tablet Contains: | glucocorticoids | |||
| Methylprednisolone | IP | 4 mg | ||||
| Excipients | q. s. | |||||
| 17 | Ursodeoxycholic Acid Tablets IP 150 mg | Each Uncoated Tablet Contains: | cholestero gallstone | |||
| Ursodeoxycholic Acid | IP | 150 mg | ||||
| Excipients | q. s. | |||||
| 18 | Ursodeoxycholic Acid Tablets IP 300 mg | Each Uncoated Tablet Contains: | ||||
| Ursodeoxycholic Acid | IP | 300 mg | cholestero gallstone | |||
| Excipients | q. s. | |||||
| 19 | Ursodeoxycholic Acid Sustained releaseTablets 500 mg | Each Filmcoated Tablet Contains: | ||||
| Ursodeoxycholic Acid | BP | 500 mg | cholestero gallstone | |||
| Excipients | q. s. | |||||
| 20 | Pantaprazole Tablets IP 40 mg | Each enteric Coated Tablet contains: | ||||
| Pantaprazole Sodium Sesquihydrate | IP | 40 mg | Proton-pump inhibitor | |||
| Eq. to Pantaprazole | ||||||
| Excipients | q. s. | |||||
| 21 | Citicolin Tablets IP 500 mg | Each Film Coated Tablet Contains: | Nootropic | |||
| Citicoline (as Sodium) | ||||||
| Eq. to Citicoline | IP | 500 mg | ||||
| Excipients | q. s. | |||||
| Cetirizine Dihydrochoride,Phenylepherine.HCL & | Each Uncoated Tablet Contains: | |||||
| Cetrizine Dihydrochloride | IP | 5mg | ||||
| Phenylephrine HCl | IP | 10mg | Anti histamine | |||
| 22 | Paracetamol | IP | 325mg | |||
| Excipients | ||||||
| 23 | Tizanidine Hcl Tablets IP | Each Uncoated Tablet Contains: | ||||
| Tizanidine HCl | IP | 2 mg | alpha-2-adrenergic agonists | |||
| Excipients | q. s. | |||||
| 24 | Levetiracetam Tablets IP | Each Film Coated Tablet Contains: | ||||
| Levetiracetam | IP | 500 mg | anticonvulsants | |||
| Excipients | q. s. | |||||
| 25 | Levetiracetam Tablets IP | Each Film Coated Tablet Contains: | ||||
| Levetiracetam | IP | 750 mg | ||||
| Excipients | q. s. | anticonvulsants | ||||
| 26 | Ketorolac Tromethamine Tablets IP | Each Uncoated Tablet Contains: | ||||
| Ketorolac Tromethamine | IP | 10 mg | ||||
| Excipients | q. s. | |||||
| 27 | Domperidone Tablets IP | Each Uncoated Tablet Contains: | ||||
| Domperidone Maleate | anti-inflammatory | |||||
| Eq. to Domperidone | IP | 10 mg | ||||
| Excipients | q. s. | |||||
| 28 | Serratiopeptidase Tablets IP | Each Film Coated Tablet Contains: | ||||
| Serratiopeptidase (Enzyme Activity-2000 unit) | IP | 10 mg | antibiotics | |||
| Excipients | q. s. | |||||
| 29 | Voriconazole Tablet IP | Each Film Coated Tablet Contains: | ||||
| Voriconazole | IP | 200 mg | ||||
| Excipients | q. s. | |||||
| 30 | Aciclovir Tablets IP | Each Uncoated Tablet Contains: | ||||
| Aciclovir | IP | 400 mg | antiviral | |||
| Excipients | q. s. | |||||
| 31 | Rosuvastatin & Fenofibrate Tablet IP | Each Film Coated Tablet Contains: | ||||
| Rosuvastatin Calcium | Lipid-Lowering Agents, Statin | |||||
| Eq. to Rosuvastatin | IP | 10 mg | ||||
| Fenofibrate (micronized) | IP | 160 mg | ||||
| Excipients | q. s. | |||||
| 32 | Nicorandil Tablets IP | Each Prolonged Release Tablet Contains: | ||||
| Nicorandil | IP | 20 mg | potassium channel activators | |||
| Excipients | q. s. | |||||
| 33 | Nicorandil Tablets IP | Each Prolonged Release Tablet Contains: | ||||
| Nicorandil | IP | 10 mg | potassium channel activators | |||
| Excipients | q. s. | |||||
| 34 | Nicorandil Tablets IP | Each Prolonged Release Tablet Contains: | ||||
| Nicorandil | IP | 5 mg | potassium channel activators | |||
| Excipients | q. s. | |||||
| 35 | Ondansertron Tablets IP | Each Uncoated Tablet Contains: | ||||
| Ondansertron Hcl | 5-HT3 receptor antagonists | |||||
| Eq. to Ondansertron | IP | 8 mg | ||||
| Excipients | q. s. | |||||
| 36 | Hydroxyzine Hcl Tablets IP | Each Uncoated Tablet Contains: | antihistamines | |||
| Hydroxyzine Hcl | IP | 10 mg | ||||
| Excipients | q. s. | |||||
| 37 | Hydroxyzine Hcl Tablets IP | Each Uncoated Tablet Contains: | ||||
| Hydroxyzine Hcl | IP | 25 mg | antihistamines | |||
| Excipients | q. s. | |||||
| 38 | Tranexamic Acid Tablets IP | Each Film Coated Tablet Contains: | ||||
| Tranexamic Acid | IP | 500 mg | antifibrinolytics | |||
| Excipients | q. s. | |||||
| 39 | Levofloxacin Tablets IP | Each Film Coated Tablet Contains: | ||||
| Levofloxacin hemi-hydrate | antibiotics | |||||
| Eq. to Levofloxacin | IP | 250 mg | ||||
| Excipients | q. s. | |||||
| 40 | Ciprofloxacin Tablets IP | Each Film Coated Tablet Contains: | bacterial infections. | |||
| Ciprofloxacin hydrochloride | ||||||
| Eq. to Ciprofloxacin | IP | 500 mg | ||||
| Excipients | q. s. | |||||
| 41 | Roxithromycin Tablets IP | Each Film Coated Tablet Contains: | macrolides | |||
| Roxithromycin | IP | 150 mg | ||||
| Excipients | q. s. | |||||
| 42 | Ramipril Tablets IP | Each Film Coated Tablet Contains: | ||||
| Ramipril | IP | 10 mg | (ACE) inhibitors. | |||
| Excipients | q. s. | |||||
| 43 | Ramipril Tablets IP | Each Film Coated Tablet Contains: | ||||
| Ramipril | IP | 5 mg | (ACE) inhibitors. | |||
| Excipients | q. s. | |||||
| 44 | Ramipril Tablets IP | Each Film Coated Tablet Contains: | ||||
| Ramipril | IP | 2.5 mg | (ACE) inhibitors. | |||
| Excipients | q. s. | |||||
| 45 | Mefenamic Acid & Dicyclomine hydrochloride Tablets IP | Each Uncoated Tablet Contains: | ||||
| Mefenamic Acid | IP | 250 mg | ||||
| Dicyclomine Hcl | IP | 10 mg | Anti-inflammatory, analgesic | |||
| Excipients | q. s. | |||||
| 46 | Torsemide Tablets IP | Each Uncoated Tablet Contains: | diuretics | |||
| Torsemide | IP | 20 mg | ||||
| Excipients | q. s. | |||||
| 47 | Olmesartan Medoxomil Tablets IP 20mg | Each Film Coated Tablet Contains: | (hypertension). | |||
| Olmesartan Medoxmil | IP | 20mg | ||||
| Excipients | q. s. | |||||
| 48 | Olmesartan Medoxomil Tablets IP 40mg | Each Film Coated Tablet Contains: | (hypertension). | |||
| Olmesartan Medoxmil | IP | 40mg | ||||
| Excipients | q. s. | |||||
| 49 | Olmesartan Medoxomil & Hydrochlothiazide Tablets IP | Each Film Coated Tablet Contains: | (hypertension). | |||
| Olmesartan Medoxmil | IP | 20 mg | ||||
| Hydrochlothiazide | IP | 12.5 mg | ||||
| Excipients | q. s. | |||||
| 50 | Olmesartan Medoxomil & Hydrochlothiazide Tablets IP | Each Film Coated Tablet Contains: | (hypertension). | |||
| Olmesartan Medoxmil | IP | 40 mg | ||||
| Hydrochlothiazide | IP | 12.5 mg | ||||
| Excipients | q. s. | |||||
| 51 | Olmesartan Medoxomil & Amlodipine Tablets | Each Film Coated Tablet Contains: | (hypertension). | |||
| Olmesartan Medoxmil | IP | 20 mg | ||||
| Amlodipine Besylate | ||||||
| Eq. to Amlodipine | IP | 5 mg | ||||
| Excipients | q. s. | |||||
| 52 | Olmesartan Medoxomil & Metoprolol Succinate (Extended Release) Tablets | Each Uncoated bilayered Tablet Contains: | (hypertension). | |||
| Olmesartan Medoxomil | IP | 20 mg | ||||
| Metoprolol Succinate | ||||||
| Eq. to Metoprolol Tartrate | IP | 50 mg | ||||
| (As extended release) | ||||||
| Excipients | q. s. | |||||
| 53 | Rosuvastatin & Fenofibrate Tablet IP | Each Film Coated Tablet Contains: | ||||
| Rosuvastatin Calcium | ||||||
| Eq. to Rosuvastatin | IP | 5 mg | statins | |||
| Fenofibrate (micronized) | IP | 160 mg | ||||
| Excipients | q. s. | |||||
| 54 | Gliclazide Tablets IP | Each Uncoated Tablet Contains: | ||||
| Gliclazide | IP | 80 mg | ||||
| Excipients | q. s. | |||||
| 55 | Gliclazide & Metformin hydrochloride Tablets | Each Uncoated Tablet Contains: | sulfonylurea. | |||
| Gliclazide | IP | 80 mg | ||||
| Metformin hydrochloride | IP | 500 mg | ||||
| Excipients | q. s. | |||||
| 56 | Cholecalciferol chewable tablet 60,000IU | Each Uncoated chewable Tablet Contains: | vitamin D analogs. | |||
| Cholecalciferol | IP | 60,000 IU | ||||
| Excipients | q. s. | |||||
| 57 | Pregabalin & Nortriptyline Tablets | Each Film Coated Tablet Contains: | antidepressants. | |||
| Pregabalin | IP | 75 mg | ||||
| Nortriptyline hydrochloride | ||||||
| Eq. to Nortriptyline | IP | 10 mg | ||||
| Excipients | q. s. | |||||
| 58 | Rosuvastatin Tablet IP 40 mg | Each Film Coated Tablet Contains: | Statin | |||
| Rosuvastatin Calcium | ||||||
| Eq. to Rosuvastatin | IP | 40 mg | ||||
| Excipients | q. s. | |||||
| 59 | Rosuvastatin Tablet IP 5 mg | Each Film Coated Tablet Contains: | Statin | |||
| Rosuvastatin Calcium | ||||||
| Eq. to Rosuvastatin | IP | 5 mg | ||||
| Excipients | q. s. | |||||
| 60 | Rosuvastatin Tablet IP 10 mg | Each Film Coated Tablet Contains: | Statin | |||
| Rosuvastatin Calcium | ||||||
| Eq. to Rosuvastatin | IP | 10 mg | ||||
| Excipients | q. s. | |||||
| 61 | Rosuvastatin Tablet IP 20 mg | Each Film Coated Tablet Contains: | Statin | |||
| Rosuvastatin Calcium | ||||||
| Eq. to Rosuvastatin | IP | 20 mg | ||||
| Excipients | q. s. | |||||
| 62 | Talmisartan Tablets IP 20 mg | Each Uncoated Tablet Contains: | hypertension | |||
| Telmisartan | IP | 20 mg | ||||
| Excipients | q. s. | |||||
| 63 | Talmisartan Tablets IP 40 mg | Each Uncoated Tablet Contains: | hypertension | |||
| Telmisartan | IP | 40 mg | ||||
| Excipients | q. s. | |||||
| 64 | Talmisartan Tablets IP 80 mg | Each Uncoated Tablet Contains: | hypertension | |||
| Telmisartan | IP | 80 mg | ||||
| Excipients | q. s. | |||||
| 65 | Talmisartan & AmlodipineTablets IP | Each Uncoated bilayeredTablet Contains: | hypertension | |||
| Telmisartan | IP | 40 mg | ||||
| Amlodipine Besylate | ||||||
| Eq. to Amlodipine | IP | 5 mg | ||||
| Excipients | q. s. | |||||
| 66 | Telmisartan &Hydrochlorthiazide Tablets IP | Each Uncoated Tablet Contains: | hypertension | |||
| Telmisartan | IP | 40 mg | ||||
| Hydrochlothiazide | IP | 12.5 mg | ||||
| Excipients | q. s. | |||||
| 67 | Pantoprazole Gastro-resistant Tablets IP 40 mg | Each Gastro-resistant Tablets Contains: | Proton-pump inhibitor | |||
| Pantaprazole Sodium Sesquihydrate | ||||||
| Eq. to Pantoprazole | IP | 40 mg | ||||
| Excipients | q. s. | |||||
| 68 | Glimepiride Tablets IP 1 mg | Each Uncoated Tablet Contains: | sulfonylureas | |||
| Glimepiride | IP | 1 mg | ||||
| Excipients | q. s. | |||||
| 69 | Glimepiride Tablets IP 2 mg | Each Uncoated Tablet Contains: | sulfonylureas | |||
| Glimepiride | IP | 2 mg | ||||
| Excipients | q. s. | |||||
| 70 | Glimepiride Tablets IP 3 mg | Each Uncoated Tablet Contains: | sulfonylureas | |||
| Glimepiride | IP | 3 mg | ||||
| Excipients | q. s. | |||||
| 71 | Glimepiride Tablets IP 4 mg | Each Uncoated Tablet Contains: | sulfonylureas | |||
| Glimepiride | IP | 4 mg | ||||
| Excipients | q. s. | |||||
| 72 | Cilnidipine Tablets IP 5 mg | Each Film Coated Tablet Contains: | ||||
| Cilnidipine | IP | 5 mg | ||||
| Excipients | q. s. | |||||
| 73 | Cilnidipine Tablets IP 10 mg | Each Film Coated Tablet Contains: | calcium channel blocker | |||
| Cilnidipine | IP | 10 mg | ||||
| Excipients | q. s. | |||||
| 74 | Cilnidipine Tablets IP 20 mg | Each Film Coated Tablet Contains: | calcium channel blocker | |||
| Cilnidipine | IP | 20 mg | ||||
| Excipients | q. s. | |||||
| 75 | Vildagliptin & Metformin Hydrochloride Tablets | Each Film Coated Tablet Contains: | antidiabetic | |||
| Vildagliptin | IP | 50 mg | ||||
| Metformin Hydrochloride | IP | 500 mg | ||||
| Excipients | q. s. | |||||
| 76 | Vildagliptin & Metformin Hydrochloride Tablets | Each Film Coated Tablet Contains: | antidiabetic | |||
| Vildagliptin | IP | 50 mg | ||||
| Metformin Hydrochloride | IP | 850 mg | ||||
| Excipients | q. s. | |||||
| 77 | Vildagliptin & Metformin Hydrochloride Tablets | Each Film Coated Tablet Contains: | antidiabetic | |||
| Vildagliptin | IP | 50 mg | ||||
| Metformin Hydrochloride | IP | 1000 mg | ||||
| Excipients | q. s. | |||||
| 78 | Atorvastatin Tablets IP 80 mg | Each Film Coated Tablet Contains: | statins. | |||
| Atorvastatin Calcium | IP | 80 mg | ||||
| eq. to Atorvastatin | ||||||
| Excipients | q. s. | |||||
| 79 | Talmisartan & AmlodipineTablets IP | Each Uncoated bilayered Tablet Contains: | hypertension | |||
| Telmisartan | IP | 80 mg | ||||
| Amlodipine Besylate | ||||||
| Eq. to Amlodipine | IP | 5 mg | ||||
| Excipients | q. s. | |||||
| 80 | Talmisartan & AmlodipineTablets IP | Each Uncoated bilayered Tablet Contains: | hypertension | |||
| Telmisartan | IP | 40 mg | ||||
| Amlodipine Besylate | ||||||
| Eq. to Amlodipine | IP | 10 mg | ||||
| Excipients | q. s. | |||||
| 81 | Talmisartan & AmlodipineTablets IP | Each Uncoated bilayered Tablet Contains: | hypertension | |||
| Telmisartan | IP | 80 mg | ||||
| Amlodipine Besylate | ||||||
| Eq. to Amlodipine | IP | 10 mg | ||||
| Excipients | q. s. | |||||
| 82 | Glimepiride, Voglibose & Metformin Hydrochloride (Sustained Release) Tablets | Each Film coated bilayered Tablet Contains: | sulfonylureas | |||
| Glimepiride | ||||||
| Voglibose | IP | 1 mg | ||||
| Metformin Hydrochloride | IP | 0.2 mg | ||||
| (As Sustained Release) | IP | 500 mg | ||||
| Excipients | ||||||
| q. s. | ||||||
| 83 | Glimepiride, Voglibose & Metformin Hydrochloride (Sustained Release) Tablets | Each Film coated bilayered Tablet Contains: | Alpha glucosidase inhibitors | |||
| Glimepiride | IP | 2 mg | ||||
| Voglibose | IP | 0.2 mg | ||||
| Metformin Hydrochloride | IP | 500 mg | ||||
| (As Sustained Release) | ||||||
| Excipients | q. s. | |||||
| 84 | Vidagliptin Tablets 50 mg | Each Uncoated Tablet Contains: | DPP-4 inhibitor. | |||
| Vidagliptin | IP | 50 mg | ||||
| Excipients | q. s. | |||||
| 85 | Teneligliptin & Metformin Hydrochloride (Extended Release) Tablets | Each Film coated bilayered Tablet Contains: | ||||
| Teneligliptin hydrobromide hydrate | anti-diabetic | |||||
| Eq. to Teneligliptin | IP | 20 mg | ||||
| Metformin Hydrochloride | IP | 500 mg | ||||
| (As Extended Release) | ||||||
| Excipients | q. s. | |||||
| 86 | Teneligliptin & Metformin Hydrochloride (Extended Release) Tablets | Each Film coated bilayered Tablet Contains: | ||||
| Teneligliptin hydrobromide hydrate | anti-diabetic | |||||
| Eq. to Teneligliptin | IP | |||||
| Metformin Hydrochloride | IP | 20 mg | ||||
| (As Extended Release) | 1000 mg | |||||
| Excipients | ||||||
| q. s. | ||||||
| 87 | Glimepiride & Metformin Hydrochloride (Sustained Release) Tablets | Each Film coated bilayered Tablet Contains: | sulfonylurea. | |||
| Glimepiride | ||||||
| Metformin Hydrochloride | IP | 1 mg | ||||
| (As Sustained Release) | IP | 500 mg | ||||
| Excipients | ||||||
| q. s. | ||||||
| 88 | Glimepiride & Metformin Hydrochloride (Sustained Release) Tablets | Each Film coated bilayered Tablet Contains: | sulfonylurea. | |||
| Glimepiride | IP | 2 mg | ||||
| Metformin Hydrochloride | IP | 500 mg | ||||
| (As Sustained Release) | ||||||
| Excipients | q. s. | |||||
| 89 | Glimepiride & Metformin Hydrochloride (Sustained Release) Tablets | Each Film coated bilayered Tablet Contains: | sulfonylurea. | |||
| Glimepiride | IP | 1 mg | ||||
| Metformin Hydrochloride | IP | 1000 mg | ||||
| (As Sustained Release) | ||||||
| Excipients | q. s. | |||||
| 90 | Glimepiride & Metformin Hydrochloride (Sustained Release) Tablets | Each Film coated bilayered Tablet Contains: | ||||
| Glimepiride | IP | 2 mg | sulfonylurea. | |||
| Metformin Hydrochloride | IP | 1000 mg | ||||
| (As Sustained Release) | ||||||
| Excipients | q. s. | |||||
| 91 | Voglibose & Metformin Hydrochloride (Sustained Release) Tablets | Each Film coated bilayered Tablet Contains: | Alpha glucosidase inhibitor | |||
| Voglibose | IP | 0.2 mg | ||||
| Metformin Hydrochloride | IP | 500 mg | ||||
| (As Sustained Release) | ||||||
| Excipients | q. s. | |||||
| 92 | Voglibose & Metformin Hydrochloride (Sustained Release) Tablets | Each Film coated bilayered Tablet Contains: | ||||
| Voglibose | IP | 0.3 mg | Alpha glucosidase inhibitor | |||
| Metformin Hydrochloride | IP | 500 mg | ||||
| (As Sustained Release) | ||||||
| Excipients | q. s. | |||||
| 93 | Telmisartan & Metoprolol Succinate (Extended release) Tablets IP | Each Uncoated bilayered Tablet Contains: | ||||
| Telmisartan | IP | 40 mg | hypertension | |||
| Metoprolol Succinate | ||||||
| Eq. to Metoprolol Tartrate | IP | 25 mg | ||||
| (As Extended Release) | ||||||
| Excipients | q. s. | |||||
| 94 | Clinidipine & Telmesartan, Chlorthalidone Tablets | Each Film Coated Tablet Contains: | ||||
| Clinidipine | IP | 10 mg | hypertension | |||
| Telmesartan | IP | 40 mg | ||||
| Chlorthalidone | IP | 12.5 mg | ||||
| Excipients | q. s. | |||||
| 95 | Rivaroxaban Tablets 10 mg | Each Film Coated Tablet Contains: | Anticoagulant | |||
| Rivaroxaban | IP | 10 mg | ||||
| Excipients | q. s. | |||||
| 96 | Rivaroxaban Tablets 15 mg | Each Film Coated Tablet Contains: | Anticoagulant | |||
| Rivaroxaban | IP | 15 mg | ||||
| Excipients | q. s. | |||||
| 97 | Rivaroxaban Tablets 20 mg | Each Film Coated Tablet Contains: | ||||
| Rivaroxaban | IP | 20 mg | Anticoagulant | |||
| Excipients | q. s. | |||||
| 98 | Metoprolol Succinate (Prolonged Release) Tablets IP 25 mg | Each Film Coated Tablet Contains: | ||||
| Metoprolol Succinate | IP | 25 mg | beta-blocker | |||
| (As Prolonged Release) | ||||||
| Excipients | q. s. | |||||
| 99 | Metoprolol Succinate (Prolonged Release) Tablets IP 50 mg | Each Film Coated Tablet Contains: | beta-blocker | |||
| Metoprolol Succinate | IP | 50 mg | ||||
| (As Prolonged Release) | ||||||
| Excipients | q. s. | |||||
| 100 | Telmisartan & Chlorthalidone Tablets | Each Uncoated bilayered Tablet Contains: | Hypertension | |||
| Telmisartan | IP | 40 mg | ||||
| Chlorthalidone | IP | 12.5 mg | ||||
| Excipients | q. s. | |||||
| 121 | Telmisartan & Chlorthalidone Tablets | Each Uncoated bilayered Tablet Contains: | ||||
| Telmisartan | IP | 40 mg | Hypertension | |||
| Chlorthalidone | IP | 6.25 mg | ||||
| Excipients | q. s. | |||||
| 122 | Metoprolol Succinate (Prolonged Release) Tablets IP 12.5 mg | Each Film Coated Tablet Contains: | ||||
| Metoprolol Succinate | IP | 12.5 mg | beta blockers | |||
| (As Prolonged Release) | ||||||
| Excipients | q. s. | |||||
| 124 | Sitagliptin & Metformin Hydrochloride Tablets | Each Film Coated Tablet Contains: | dipeptidylpeptidase-4 inhibitors | |||
| Sitagliptin Phosphate monohydrate | ||||||
| Eq. to Sitagliptin | IP | 50 mg | ||||
| Metformin Hydrochloride | IP | 500 mg | ||||
| Excipients | q. s. | |||||
| 125 | Sitagliptin & Metformin Hydrochloride Tablets | Each Film Coated Tablet Contains: | ||||
| Sitagliptin Phosphate monohydrate | dipeptidylpeptidase-4 inhibitors | |||||
| Eq. to Sitagliptin | IP | 50 mg | ||||
| Metformin Hydrochloride | IP | 1000 mg | ||||
| Excipients | q. s. | |||||
| 126 | Torsemide Tablets IP 5 mg | Each Uncoated Tablet Contains: | ||||
| Torsemide | IP | 5 mg | diuretics ('water pills'). | |||
| Excipients | q. s. | |||||
| 127 | Torsemide Tablets IP 10 mg | Each Uncoated Tablet Contains: | ||||
| Torsemide | IP | 10 mg | diuretics ('water pills'). | |||
| Excipients | q. s. | |||||
| 128 | Torsemide Tablets IP 100 mg | Each Uncoated Tablet Contains: | ||||
| Torsemide | IP | 100 mg | diuretics ('water pills'). | |||
| Excipients | q. s. | |||||
| 129 | Telmisertan & Clinidipine Tablets | Each Film Coated Tablet Contains: | Hypertension | |||
| Telmisertan | IP | 40 mg | ||||
| Clinidipine | IP | 5 mg | ||||
| Excipients | q. s. | |||||
| 130 | Telmisertan & Clinidipine Tablets | Each Film Coated Tablet Contains: | ||||
| Telmisertan | ||||||
| Clinidipine | IP | 40 mg | ||||
| Excipients | IP | 10 mg | ||||
| q. s. | ||||||
| 131 | Telmisartan & Metoprolol Succinate (Extended release) Tablets IP | Each Uncoated bilayered Tablet Contains: | Hypertension | |||
| Telmisartan | ||||||
| Metoprolol Succinate | IP | 40 mg | ||||
| Eq. to Metoprolol Tartrate | ||||||
| (As Extended Release) | IP | 50 mg | ||||
| Excipients | ||||||
| q. s. | ||||||
| 132 | Sitagliptin Tablets | Each Film Coated Tablet Contains: | ||||
| Sitagliptin Phosphate monohydrate | Anti-Diabetes | |||||
| Eq. to Sitagliptin | IP | 25 mg | ||||
| Excipients | q. s. | |||||
| 133 | Sitagliptin Tablets | Each Film Coated Tablet Contains: | Anti-Diabetes | |||
| Sitagliptin Phosphate monohydrate | ||||||
| Eq. to Sitagliptin | IP | 50 mg | ||||
| Excipients | q. s. | |||||
| 134 | Sitagliptin Tablets | Each Film Coated Tablet Contains: | ||||
| Sitagliptin Phosphate monohydrate | ||||||
| Eq. to Sitagliptin | IP | 100 mg | Anti-Diabetes | |||
| Excipients | q. s. | |||||
| 135 | Gliclazide & Metformin hydrochloride (Extanded Release) Tablets | Each Film Coated bilayered Tablet Contains: | ||||
| Gliclazide | IP | 30 mg | sulfonylurea. | |||
| (As Extended Release) | ||||||
| Metformin hydrochloride | IP | 500 mg | ||||
| (As Extended Release) | ||||||
| Excipients | q. s. | |||||
| 136 | Gliclazide & Metformin hydrochloride (Extanded Release) Tablets | Each Film Coated bilayered Tablet Contains: | ||||
| Gliclazide | IP | 60 mg | sulfonylurea. | |||
| (As Extended Release) | ||||||
| Metformin hydrochloride | IP | 500 mg | ||||
| (As Extended Release) | ||||||
| Excipients | q. s. | |||||
| 137 | Gliclazide Modified Release Tablets 30 mg | Each Uncoated Modified Release Tablet Contains: | ||||
| Gliclazide | IP | 30 mg | sulfonylurea. | |||
| (As Modified Release) | ||||||
| Excipients | q. s. | |||||
| 138 | Gliclazide Modified Release Tablets 60 mg | Each Uncoated Modified Release Tablet Contains: | ||||
| Gliclazide | IP | 60 mg | ||||
| (As Modified Release) | sulfonylurea. | |||||
| Excipients | q. s. | |||||
| 139 | Repaglinide Tablet IP 0.5 mg | Each Uncoated Tablet Contains: | ||||
| Repaglinide | IP | 0.5 mg | Anti-diabetes | |||
| Excipients | q. s. | |||||
| 140 | Repaglinide Tablet IP 1 mg | Each Uncoated Tablet Contains: | ||||
| Repaglinide | IP | 1 mg | Anti-diabetes | |||
| Excipients | q. s. | |||||
| 141 | Repaglinide Tablet IP 2 mg | Each Uncoated Tablet Contains: | ||||
| Repaglinide | IP | 2 mg | Anti-diabetes | |||
| Excipients | q. s. | |||||
| 142 | Repaglinide & Metformin hydrochloride Tablet IP | Each Film Coated Tablet Contains: | ||||
| Repaglinide | IP | 1 mg | Anti-diabetes | |||
| Metformin hydrochloride | IP | 500 mg | ||||
| Excipients | q. s. | |||||
| 143 | Repaglinide & Metformin hydrochloride Tablet IP | Each Film Coated Tablet Contains: | ||||
| Repaglinide | IP | 2 mg | ||||
| Metformin hydrochloride | IP | 500 mg | Anti-diabetes | |||
| Excipients | q. s. | |||||
| 144 | Atorvastatin Tablets IP 10 mg | Each Film Coated Tablet Contains: | ||||
| Atorvastatin Calcium | IP | 10 mg | HMG-CoA reductase inhibitors | |||
| eq. to Atorvastatin | ||||||
| Excipients | q. s. | |||||
| 145 | Atorvastatin Tablets IP 40 mg | Each Film Coated Tablet Contains: | ||||
| Atorvastatin Calcium | IP | 40 mg | HMG-CoA reductase inhibitors | |||
| eq. to Atorvastatin | ||||||
| Excipients | q. s. | |||||
| 146 | Metoprolol Succinate (Sustained Release) & Amlodipine Tablets IP | Each Film Coated bilayered Tablet Contains: | ||||
| Metoprolol Succinate | beta-blocker | |||||
| Eq. to Metoprolol Tartrate | IP | 50 mg | ||||
| Amlodipine Besylate | ||||||
| Eq. to Amlodipine | IP | 5 mg | ||||
| Excipients | q. s. | |||||
| 147 | Metoprolol Succinate (Sustained Release) & Amlodipine Tablets IP | Each Film Coated bilayered Tablet Contains: | ||||
| Metoprolol Succinate | ||||||
| Eq. to Metoprolol Tartrate | IP | 25 mg | beta-blocker | |||
| Amlodipine Besylate | ||||||
| Eq. to Amlodipine | IP | 5 mg | ||||
| Excipients | q. s. | |||||
| 148 | Dapagliflozin Tablets 5 mg | Each Film Coated Tablet Contains: | ||||
| Dapagliflozin propanediol monohydrate | sodium-glucose co-transporte | |||||
| Eq. to Dapagliflozin | 5 mg | |||||
| Excipients | q. s. | |||||
| 149 | Dapagliflozin Tablets 5 mg | Each Film Coated Tablet Contains: | ||||
| Dapagliflozin propanediol monohydrate | ||||||
| Eq. to Dapagliflozin | 10 mg | sodium-glucose co-transporte | ||||
| Excipients | q. s. | |||||
| 150 | Empagliflozin Tablets 10 mg | Each Film Coated Tablet Contains: | ||||
| Empagliflozin | 10 mg | Antidiabetes | ||||
| Excipients | q. s. | |||||
| 151 | Empagliflozin Tablets 20 mg | Each Film Coated Tablet Contains: | ||||
| Empagliflozin | 20 mg | Antidiabetes | ||||
| Excipients | q. s. | |||||
| 152 | Empagliflozin Tablets 25 mg | Each Film Coated Tablet Contains: | ||||
| Empagliflozin | 25 mg | Antidiabetes | ||||
| Excipients | q. s. | |||||
| 153 | Saxagliptin & Metformin hydrochloride (Extended Release) Tablets IP | Each Film Coated bilayered Tablet Contains: | ||||
| Saxagliptin hydrochloride | ||||||
| Eq. to Saxagliptin | 5 mg | sodium-glucose co-transporter | ||||
| Metformin hydrochloride | IP | 1000 mg | ||||
| (As Extended Release) | ||||||
| Excipients | q. s. | |||||
| 154 | Metformin hydrochloride (Sustained Release) Tablets IP | Each Uncoated Sustained Release Tablet Contains: | ||||
| Metformin hydrochloride | IP | 500 mg | biguanides. | |||
| (As Sustained Release) | ||||||
| Excipients | q. s. | |||||
| 155 | Metformin hydrochloride (Sustained Release) Tablets IP | Each Uncoated Sustained Release Tablet Contains: | ||||
| Metformin hydrochloride | IP | 850 mg | biguanides. | |||
| (As Sustained Release) | ||||||
| Excipients | q. s. | |||||
| 156 | Metformin hydrochloride (Sustained Release) Tablets IP | Each Uncoated Sustained Release Tablet Contains: | ||||
| Metformin hydrochloride | IP | 1000 mg | biguanides. | |||
| (As Sustained Release) | ||||||
| Excipients | q. s. | |||||
| 157 | Metformin hydrochloride Tablets IP | Each Uncoated Tablet Contains: | ||||
| Metformin hydrochloride | IP | 500 mg | biguanides. | |||
| (As Sustained Release) | ||||||
| Excipients | q. s. | |||||
| 159 | Metformin hydrochloride Tablets IP | Each Uncoated Tablet Contains: | ||||
| Metformin hydrochloride | IP | 850 mg | biguanides. | |||
| (As Sustained Release) | ||||||
| Excipients | q. s. | |||||
| 160 | Metformin hydrochloride Tablets IP | Each Uncoated Tablet Contains: | ||||
| Metformin hydrochloride | IP | 1000 mg | biguanides. | |||
| (As Sustained Release) | ||||||
| Excipients | q. s. | |||||
| 161 | Ticagrelor Tablets IP 60 mg | Each Film Coated Tablet Contains: | ||||
| Ticagrelor | IP | 60 mg | Antithrombotic | |||
| Excipients | q. s. | |||||
| 162 | Ticagrelor Tablets IP 90 mg | Each Film Coated Tablet Contains: | ||||
| Ticagrelor | IP | 90 mg | Antithrombotic | |||
| Excipients | q. s. | |||||
| 163 | Rosuvastatin & Ezetimibe Tablets IP | Each Film Coated Tablet Contains: | ||||
| Rosuvastatin Calcium | Cholesterol absorption inhibitor | |||||
| Eq. to Rosuvastatin | IP | 10 mg | ||||
| Ezetimibe | IP | 10 mg | ||||
| Excipients | q. s. | |||||
| 164 | Rosuvastatin & Ezetimibe Tablets IP | Each Film Coated Tablet Contains: | ||||
| Rosuvastatin Calcium | Cholesterol absorption inhibitor | |||||
| Eq. to Rosuvastatin | IP | 20 mg | ||||
| Ezetimibe | IP | 10 mg | ||||
| Excipients | q. s. | |||||
| 165 | Ezetimibe Tablets IP | Each Uncoated Tablet Contains: | ||||
| Ezetimibe | IP | 10 mg | absorption of cholesterol | |||
| Excipients | q. s. | |||||
| 166 | Torsemide & Spironolactone Tablets IP | Each Uncoated Tablet Contains: | ||||
| Torsemide | IP | 10 mg | Aldosterone Antagonists | |||
| Spironolactone | IP | 50 mg | ||||
| Excipients | q. s. | |||||
| 177 | Torsemide & Spironolactone Tablets IP | Each Uncoated Tablet Contains: | ||||
| Torsemide | IP | 20 mg | Aldosterone Antagonists | |||
| Spironolactone | IP | 50 mg | ||||
| Excipients | q. s. | |||||
| 178 | Cilnidipine & Metoprolol Succinate (ER) Tablets | Each Uncoated bilayered Tablets Contains: | ||||
| Cilnidipine | IP | 10 mg | Hypertension | |||
| Metoprolol Succinate | ||||||
| Eq. to Metoprolol Tartrate | IP | 50 mg | ||||
| (In Extended Release form) | ||||||
| Excipients | q. s. | |||||
| 179 | Cilnidipine & Metoprolol Succinate (ER) Tablets | Each Uncoated bilayered Tablets Contains: | ||||
| Cilnidipine | IP | 10 mg | Hypertension | |||
| Metoprolol Succinate | ||||||
| Eq. to Metoprolol Tartrate | IP | 25 mg | ||||
| (In Extended Release form) | ||||||
| Excipients | q. s. | |||||
| 180 | Olmesartan Medoxomil Tablets IP 10 mg | Each Film Coated Tablet Contains: | ||||
| Olmesartan Medoxomil | IP | 10 mg | hypertension | |||
| Excipients | q. s. | |||||
| 181 | Olmesartan Medoxomil & Amlodipine Tablets | Each Film Coated Tablet Contains: | ||||
| Olmesartan Medoxomil | IP | 40 mg | hypertension | |||
| Amlodipine Besylate | ||||||
| Eq. to Amlodipine | IP | 5 mg | ||||
| Excipients | q. s. | |||||
| 182 | Olmesartan Medoxomil, Amlodipine & Hydrochlorothiazide Tablets | Each Film Coated Tablet Contains: | ||||
| Olmesartan Medoxomil | IP | 40 mg | hypertension | |||
| Amlodipine Besylate | ||||||
| Eq. to Amlodipine | IP | 5 mg | ||||
| Hydrochlorothiazide | IP | 12.5 mg | ||||
| Excipients | q. s. | |||||
| 183 | Olmesartan Medoxomil, Amlodipine & Hydrochlorothiazide Tablets | Each Film Coated Tablet Contains: | ||||
| Olmesartan Medoxomil | IP | 20 mg | hypertension | |||
| Amlodipine Besylate | ||||||
| Eq. to Amlodipine | IP | 5 mg | ||||
| Hydrochlorothiazide | IP | 12.5 mg | ||||
| Excipients | q. s. | |||||
| 184 | Clopidogrel Bisulphate Tablets | Each Film Coated Tablet Contains: | ||||
| Clopidogrel Bisulphate | Antithrombotic. | |||||
| Eq. to Clopidogrel | IP | 75 mg | ||||
| Excipients | q. s. | |||||
| 185 | Pregabalin & Methylcobalamin Tablets | Each Film Coated Tablet Contains: | ||||
| Pregabalin | IP | 75 mg | vitamin B12 | |||
| Methylcobalamin | IP | 750 mcg | ||||
| Excipients | q. s. | |||||
| 186 | Levofloxacin Tablets IP | Each Film Coated Tablet Contains: | ||||
| Levofloxacin hemi-hydrate | antibiotics | |||||
| Eq. to Levofloxacin | IP | 750 mg | ||||
| Excipients | q. s. | |||||
| Colour: Red Oxide of Iron, Yellow Oxide of Iron & Titanium Dioxide IP | ||||||
| 187 | Atorvastatin Tablets IP 20 mg | Each Film Coated Tablet Contains: | Statin | |||
| Atorvastatin Calcium | ||||||
| Eq. to Atorvastatin | IP | 20 mg | ||||
| Excipients | q. s. | |||||
| 188 | Cholecalciferol chewable tablet 60,000IU | Each Uncoated chewable Tablet Contains: | ||||
| Cholecalciferol | IP | 60,000 IU | vitamin | |||
| Excipients | q. s. | |||||
| Colour: Lake Sunset Yellow | ||||||
| 189 | Calcium Citrate, Vitamin D3, Magnesium Hydroxide & Zinc Sulphate Tablets | Each Film Coated Tablet Contains: | ||||
| Calcium Citrate | USP | 1000 mg | ||||
| Vitamin D3 | IP | 200 IU | vitamin | |||
| Magnesium Hydroxide | ||||||
| Eq. to Elemental Magnesium Zinc Sulphate | ||||||
| Monohydrate IP | IP | 100 mg | ||||
| Excipients | ||||||
| 190 | Ofloxacin & Satranidazole Tablets | Each Film Coated Tablet Contains: | ||||
| Ofloxacin | IP | 200 mg | quinolone antibiotics | |||
| Satranidazole | 300 mg | |||||
| Excipients | q. s. | |||||
| 191 | Paracetamol, phenylephrine Hcl, Caffeine & Diphenhydramine Hcl Tablets | Each Uncoated Tablet Contains: | ||||
| Paracetamol | IP | 325 mg | antiallergic | |||
| Phenylephrine Hcl | IP | 5 mg | ||||
| Caffeine (Anhydrous) | IP | 30 mg | ||||
| Diphenhydramine Hcl | IP | 25 mg | ||||
| Excipients | q. s. | |||||
| 192 | Frusemide Tablets IP | Each Uncoated Tablet Contains: | ||||
| Frusemide | IP | 40 mg | Diuretic | |||
| Excipients | q. s. | |||||
| 193 | Etoricoxib Tablets IP 90 mg | Each Film Coated Tablet Contains: | ||||
| Etoricoxib | IP | 90 mg | anti-inflammatory drugs | |||
| Excipients | q. s. | |||||
| 194 | Citicoline & Piracetam Tablets | Each Film Coated Tablet Contains: | psychostimulants and nootropics. | |||
| Citicoline Sodium | ||||||
| Eq. to Citicoline | IP | 500 mg | ||||
| Piracetam | IP | 400 mg | ||||
| Excipients | q. s. | |||||
| 195 | Artemether & Lumefantrine Tablets | Each Uncoated Tablet Contains: | Antimalarials | |||
| Artemether | IP | 20 mg | ||||
| Lumefantrine | 120 mg | |||||
| Excipients | q. s. | |||||
| 196 | Artemether & Lumefantrine Dispersible Tablets | Each Uncoated Dispersible Tablet Contains: | ||||
| Artemether | IP | 40 mg | Antimalarials | |||
| Lumefantrine | 240 mg | |||||
| Excipients | q. s. | |||||
| 197 | Artemether & Lumefantrine Tablets | Each Filmcoated Tablets Contains: | ||||
| Artemether | IP | 80 mg | Antimalarials | |||
| Lumefantrine | 480 mg | |||||
| Excipients | q. s. | |||||
| 198 | Vitamin C Chewable Tablets | Each Uncoated Tablet Contains: | ||||
| Ascorbic Acid | IP | 100 mg | Vitamin | |||
| Sodium Ascorbate | IP | 450 mg | ||||
| Eq. to Ascorbic Acid | 400 mg | |||||
| Excipients | q. s. | |||||
| Colour: Sunset Yellow FCF | ||||||
| 199 | Nimesulide, Phenylephrine hydrochloride & Levocetirizine Hydrochloride Tablets | Each Uncoated Tablet Contains: | ||||
| Nimesulide | BP | 100 mg | anti-inflammatory drug | |||
| Phenylephrine hydrochloride | IP | 5 mg | ||||
| Levocetirizine Hydrochloride | IP | 5 mg | ||||
| Excipients | q. s. | |||||
| 200 | Levocetirizine hydrochloride, Phenyleprine hydrochloride & Paracetamol Tablets | Each Uncoated Tablet Contains: | ||||
| Levocetirizine hydrochloride | IP | 5 mg | antiallergic | |||
| Phenyleprine hydrochloride | IP | 5 mg | ||||
| Paracetamol | IP | 325 mg | ||||
| Excipients | q. s. | |||||
| 201 | Aceclofenac, Paracetamol & Serratiopeptidase Tablets | Each Film Coated Tablet Contains: | ||||
| Aceclofenac | IP | 100 mg | ||||
| Paracetamol | IP | 325 mg | anti-inflammatory drug | |||
| Serratiopeptidase (As enteric coated granules) | IP | 15 mg | ||||
| Eq. to 30,000 Serratiopeptidase Units) | ||||||
| Excipients | q. s. | |||||
| 202 | Aceclofenac, Paracetamol & Chlorzoxazone Tablets | Each Film Coated Tablet Contains: | ||||
| Aceclofenac | IP | 100 mg | inflammation (redness and swelling) | |||
| Paracetamol | IP | 325 mg | ||||
| Chlorzoxazone | USP | 500 mg | ||||
| Excipients | q. s. | |||||
| 203 | Aceclofenac, Paracetamol & Serratiopeptidase Tablets | Each Film Coated Tablet Contains: | ||||
| Aceclofenac | IP | 100 mg | anti-inflammatory drug | |||
| Paracetamol | IP | 325 mg | ||||
| Serratiopeptidase (As enteric coated granules) | IP | 10 mg | ||||
| Eq. to 20,000 Serratiopeptidase Units) | ||||||
| Excipients | q. s. | |||||
| 204 | Acebrophylline, Fexofenadine hydrochloride & Montelukast Tablets | Each Film Coated Tablet Contains: | ||||
| Acebrophylline | 200 mg | acute or chronic bronchitis | ||||
| (As Sustained Release) | ||||||
| Fexofenadine hydrochloride | IP | 120 mg | ||||
| Montelukast Sodium | ||||||
| Eq. to Montelukast | IP | 10 mg | ||||
| Excipients | ||||||
| 205 | Phenylephrine Hcl, Dextromethorpan Hcl, Cetirizine, Ambroxol Hcl & Guaiphenesin Tablets | Each 5 ml contains: | ||||
| Phenylephrine hydrochloride | IP | 15 mg | ||||
| Cetirizine hydrochloride | IP | 5 mg | Anti-allgeric | |||
| Ambroxol hydrochloride | IP | 30 mg | ||||
| Dextromethorpan hydrochloride | IP | 10 mg | ||||
| Guaiphenesin | IP | 100 mg | ||||
| Excipients | q. s. | |||||
| 206 | Nimesulide, Paracetamol, Phenylephrine hydrochloride & Caffeine Tablets | Each Uncoated Tablet Contains: | ||||
| Nimesulide | 100 mg | anti-inflammatory drug | ||||
| Paracetamol | 325 mg | |||||
| Phenylephrine hydrochloride | 10 mg | |||||
| Caffeine (Anhydrous) | 25 mg | |||||
| Excipients | q. s. | |||||
| 207 | Diclofenac Sodium, Paracetamol, Cetirizine & Magnesium Trisilicate Tablets | Each Uncoated Tablet Contains: | anti-inflammatory drug | |||
| Each Uncoated Tablet Contains: | IP | 50 mg | ||||
| Paracetamol | IP | 325 mg | ||||
| Cetirizine Dihydrochloride | IP | 5 mg | ||||
| Magnesium Trisilicate | IP | 100 mg | ||||
| Excipients | q. s. | |||||
| 208 | Ascorbic acid tablets 100 mg | Each uncoated chewable tablets contains: | ||||
| Ascorbic acid | IP | 100 mg | Vitamin | |||
| Excipients | q. s. | |||||
| Approved colour used in tablets | ||||||
| 209 | Carbonyl Iron, Folic Acid, Vitamin B12 & Zinc Sulphate Tablets | Each Film Coated Tablet Contains: | ||||
| Carbonyl iron | IP | 100mg | Vitamin | |||
| Eq.to elemental iron | ||||||
| Folic acid | IP | 1.5mg | ||||
| Vitamin B12 | IP | 15mg | ||||
| Zinc sulphate monohydrate | IP | 22.5mg | ||||
| Excipients | q. s. | |||||
| Approbved colour used in tablets | ||||||
| 210 | Thiamine hydrochloride Tablets 100 mg | Each Film Coated Tablet Contains: | vitamin | |||
| Thiamine hydrochloride | IP | 100mg | ||||
| Excipients | q. s. | |||||
| Approbved colour used in tablets | ||||||
| 211 | Ferrous Ascorbate, Folic Acid, Cyanocobalamin & Zinc Sulphate Tablets | Each Film Coated Tablet Contains: | vitamin | |||
| Ferrous ascorbate | ||||||
| Eq.to elemental iron | IP | 100mg | ||||
| Folic acid | IP | 1.5mg | ||||
| Cyanocobalamin triturate | ||||||
| Eq.to Cyanocobalamin | IP | 7.5mg | ||||
| Zinc sulphate monohydrate | IP | 22.5mg | ||||
| Eq.to elemental zinc | q. s. | |||||
| Excipients | ||||||
| Approbved colour used in tablets | ||||||
| 212 | Aceclofenac & Serratiopeptidase Tablets | Each Film Coated Tablet Contains: | ||||
| Aceclofenac | IP | 100 mg | anti-inflammatory drug | |||
| Serratiopeptidase | IP | 15 mg | ||||
| (As enteric Coated granules) | ||||||
| Eq. to 30,000 Serratiopeptidase Unit | ||||||
| Excipients | q. s. | |||||
| 213 | Aceclofenac & Thiocolchicoside Tablets | Each Film Coated Tablet Contains: | ||||
| Aceclofenac | IP | 100 mg | anti-inflammatory drug | |||
| Thiocolchicoside | IP | 4 mg | ||||
| Excipients | q. s. | |||||
| 214 | Aceclofenac & Thiocolchicoside Tablets | Each Film Coated Tablet Contains: | ||||
| Aceclofenac | IP | 100 mg | anti-inflammatory drug | |||
| Thiocolchicoside | IP | 8 mg | ||||
| Excipients | q. s. | |||||
| 215 | Aceclofenac Sustained Release Tablets | Each Film Coated Sustained release Tablets Contains: | ||||
| Aceclofenac | IP | 200 mg | anti-inflammatory drug | |||
| Excipients | q. s. | |||||
| 216 | Aceclofenac, Paracetamol & Thiocolchicoside Tablets | Each Film Coated Tablet Contains: | anti-inflammatory drug | |||
| Aceclofenac | IP | 100 mg | ||||
| Paracetamol | IP | 325 mg | ||||
| Thiocolchicoside | IP | 4 mg | ||||
| Excipients | q. s. | |||||
| 217 | Aceclofenac, Paracetamol & Thiocolchicoside Tablets | Each Film Coated Tablet Contains: | anti-inflammatory drug | |||
| Aceclofenac | IP | 100 mg | ||||
| Paracetamol | IP | 325 mg | ||||
| Thiocolchicoside | IP | 8 mg | ||||
| Excipients | q. s. | |||||
| 218 | Aceclofenac, Paracetamol & Chorzoxazone Tablets | Each Film Coated Tablet Contains: | anti-inflammatory drug | |||
| Aceclofenac | IP | 100 mg | ||||
| Paracetamol | IP | 325 mg | ||||
| Chorzoxazone | USP | 500 mg | ||||
| Excipients | q. s. | |||||
| 219 | Aceclofenac, Paracetamol & Chorzoxazone Tablets | Each Film Coated Tablet Contains: | anti-inflammatory drug | |||
| Aceclofenac | IP | 100 mg | ||||
| Paracetamol | IP | 325 mg | ||||
| Chorzoxazone | USP | 250 mg | ||||
| Excipients | q. s. | |||||
| 220 | Aceclofenac, Paracetamol & Chorzoxazone Tablets | Each Uncoated Tablet Contains: | anti-inflammatory drug | |||
| Aceclofenac | IP | 100 mg | ||||
| Paracetamol | IP | 325 mg | ||||
| Chorzoxazone | USP | 250 mg | ||||
| Excipients | q. s. | |||||
| 221 | Acyclovir Tablets IP 800 mg | Each Uncoated Tablet Contains: | Anti-viral | |||
| Acyclovir | IP | 800 mg | ||||
| Excipients | q. s. | |||||
| 222 | Acyclovir Dispersible Tablets IP 200 mg | Each Uncoated Dispersible Tablet Contains: | Anti-viral | |||
| Acyclovir | IP | 200 mg | ||||
| Excipients | q. s. | |||||
| 223 | Acyclovir Dispersible Tablets IP 400 mg | Each Uncoated Dispersible Tablet Contains: | ||||
| Acyclovir | IP | 400 mg | Anti-viral | |||
| Excipients | q. s. | |||||
| 224 | Ivermectin & Albendazole Tablets | Each Uncoated Tablet Contains: | antihelmintics | |||
| Ivermectin | BP | 6 mg | ||||
| Albendazole | IP | 400 mg | ||||
| Excipients | q. s. | |||||
| 225 | Amlodipine and Atenolol Tablets | Each Uncoated Tablet Contains: | ||||
| Amlodipine Besylate | ||||||
| Eq. to Amlodipine | IP | 5 mg | ||||
| Atenolol | IP | 25 mg | ||||
| Excipients | q. s. | |||||
| 226 | Amlodipine and Atenolol Tablets | Each Uncoated Tablet Contains: | calcium channel blockers | |||
| Amlodipine Besylate | ||||||
| Eq. to Amlodipine | IP | 5 mg | ||||
| Atenolol | IP | 50 mg | ||||
| Excipients | q. s. | |||||
| 227 | Amlodipine and Telmisartan Tablets | Each Uncoated Tablet Contains: | hypersion | |||
| Amlodipine Besylate | ||||||
| Eq. to Amlodipine | IP | 5 mg | ||||
| Telmisartan | IP | 80 mg | ||||
| Excipients | q. s. | |||||
| 228 | Artemether & Lumefantrine Dispersible Tablets | Each Uncoated Dispersible Tablet Contains: | Anti-malarial. | |||
| Artemether | IP | 20 mg | ||||
| Lumefantrine | 120 mg | |||||
| Excipients | q. s. | |||||
| 229 | Artemether & Lumefantrine Tablets | Each Uncoated Tablet Contains: | Anti-malarial. | |||
| Artemether | IP | 80 mg | ||||
| Lumefantrine | 480 mg | |||||
| Excipients | q. s. | |||||
| 230 | Artemether & Lumefantrine Tablets | Each Uncoated Tablet Contains: | ||||
| Artemether | IP | 20 mg | ||||
| Lumefantrine | 120 mg | |||||
| Excipients | q. s. | |||||
| 231 | Artemether & Lumefantrine Tablets | Each Film Coated Tablet Contains: | Anti-malarial. | |||
| Artemether | IP | 80 mg | ||||
| Lumefantrine | 480 mg | |||||
| Excipients | q. s. | |||||
| 232 | Artesunate, Sulphadoxine & Pyrimethamine Combi Kit | Each Combi Kit Contains: | ||||
| (A) 1 Sulphadoxine and Pyrimethamine Tablets IP | ||||||
| Each Uncoated Tablet Contains: | Antimalarial. | |||||
| Sulphadoxine | IP | 500 mg | ||||
| Pyrimethamine | IP | 25 mg | ||||
| (B) 2 Artesunate Tablets | ||||||
| Each Uncoated Tablet Contains: | ||||||
| Artesunate | IP | 100 mg | ||||
| Approbved colour used in tablets | ||||||
| 233 | Artesunate, Sulphadoxine & Pyrimethamine Combi Kit | Each Combi Kit Contains: | ||||
| (A) 1 Sulphadoxine and Pyrimethamine Tablets IP | ||||||
| Each Uncoated Tablet Contains: | Antimalarial. | |||||
| Sulphadoxine | IP | 500 mg | ||||
| Pyrimethamine | IP | 25 mg | ||||
| (B) 2 Artesunate Tablets | ||||||
| Each Uncoated Tablet Contains: | ||||||
| Artesunate | IP | 50 mg | ||||
| Approbved colour used in tablets | ||||||
| 234 | Artesunate, Sulphadoxine & Pyrimethamine Combi Kit | Each Combi Kit Contains: | ||||
| (A) 1 Sulphadoxine and Pyrimethamine Tablets IP | ||||||
| Each Uncoated Tablet Contains: | Antimalarial. | |||||
| Sulphadoxine | IP | 750 mg | ||||
| Pyrimethamine | IP | 37.5 mg | ||||
| (B) 2 Artesunate Tablets | ||||||
| Each Uncoated Tablet Contains: | ||||||
| Artesunate | IP | 200 mg | ||||
| Approbved colour used in tablets | ||||||
| 235 | Clonazapam Mouth Dissolving Tablets 0.25 mg | Each Uncoated Mouth Dissolving Tablet Contains: | anticonvulsant or antiepileptic drug | |||
| Clonazapam | IP | 0.25 mg | ||||
| Excipients | q. s. | |||||
| 236 | Clonazapam Mouth Dissolving Tablets 0.5 mg | Each Uncoated Mouth Dissolving Tablet Contains: | ||||
| Clonazapam | IP | 0.5 mg | anticonvulsant or antiepileptic drug | |||
| Excipients | q. s. | |||||
| 237 | Clopidogrel & Aspirin Tablets | Each Film Coated Tablet Contains: | Thienopyridine | |||
| Clopidogrel Bisulphate | ||||||
| Eq. to Clopidogrel | IP | 75 mg | ||||
| Aspirin | IP | 150 mg | ||||
| Excipients | q. s. | |||||
| 238 | Diclofenac Sodium Tablets IP 50 mg | Each Uncoated Tablet Contains: | inflammatory drugs (NSAIDs | |||
| Diclofenac Sodium | ||||||
| (As enteric Coated granules) | IP | 50 mg | ||||
| Excipients | q. s. | |||||
| 239 | Disulfiram Tablets IP 500 mg | Each Uncoated Tablet Contains: | Psychiatry Agents | |||
| Disulfiram | IP | 500 mg | ||||
| Excipients | q. s. | |||||
| 240 | Drotaverine Tablets IP 40 mg | Each Film Coated Tablet Contains: | anti-spasmodic | |||
| Drotaverine hydrochloride | IP | 40 mg | ||||
| Excipients | q. s. | |||||
| 241 | Drotaverine Tablets IP 80 mg | Each Film Coated Tablet Contains: | anti-spasmodic | |||
| Drotaverine hydrochloride | IP | 40 mg | ||||
| Excipients | q. s. | |||||
| 242 | Escitalopram Tablet IP 5 mg | Each Film Coated Tablet Contains: | selective serotonin reuptake inhibitors | |||
| Escitalopram Oxalate | depression and anxiety. | |||||
| Eq. to Escitalopram | IP | 5 mg | ||||
| Excipients | q. s. | |||||
| 243 | Escitalopram Tablet IP 20 mg | Each Film Coated Tablet Contains: | ||||
| Escitalopram Oxalate | selective serotonin reuptake inhibitors | |||||
| Eq. to Escitalopram | IP | 20 mg | depression and anxiety. | |||
| Excipients | q. s. | |||||
| 244 | Glibenclamide & Metformin Tablets | Each Uncoated Tablet Contains: | antidiabetic medicines: | |||
| Glibenclamide | IP | 2.5 mg | ||||
| Metformin Hcl | IP | 400 mg | ||||
| Excipients | q. s. | |||||
| 245 | Glibenclamide & Metformin Tablets | Each Uncoated Tablet Contains: | ||||
| Glibenclamide | IP | 5 mg | antidiabetic medicines: | |||
| Metformin Hcl | IP | 500 mg | ||||
| Excipients | q. s. | |||||
| 246 | Glimepiride & Metformin Prolonged Release Tablets IP | Each Uncoated bilayered Tablets Contains: | ||||
| Glimepiride | IP | 1 mg | Hypoglycaemic. | |||
| Metformin Hcl (As Extended Release) | IP | 500 mg | ||||
| Excipients | q. s. | |||||
| 247 | Glimepiride & Metformin Prolonged Release Tablets IP | Each Uncoated bilayered Tablets Contains: | ||||
| Glimepiride | IP | 2 mg | Hypoglycaemic. | |||
| Metformin Hcl (As Extended Release) | IP | 500 mg | ||||
| Excipients | q. s. | |||||
| 249 | Hydroxychloroquien Sulphate Tablets IP 200 mg | Each Film Coated Tablet Contains: | antimalarials | |||
| Hydroxychloroquien Sulphate | IP | 200 mg | ||||
| Excipients | q. s. | |||||
| 250 | Hydroxychloroquien Sulphate Tablets IP 400 mg | Each Film Coated Tablet Contains: | antimalarials | |||
| Hydroxychloroquien Sulphate | IP | 400 mg | ||||
| Excipients | q. s. | |||||
| 251 | Ivermectin & Albendazole Tablets | Each Uncoated Tablet Contains: | antihelmintics. | |||
| Ivermectin | BP | 12 mg | ||||
| Albendazole | IP | 400 mg | ||||
| Excipients | q. s. | |||||
| 252 | Levocetirizine & Ambroxol hydrochloride Sustained Release Tablets | Each Uncoated bilayered Tablets Contains: | antiallergic | |||
| Levocetirizine Dihydrochloride | IP | 5 mg | ||||
| Ambroxol hydrochloride (In Sustained release form) | IP | 75 mg | ||||
| Excipients | q. s. | |||||
| 253 | Losartan Potassium & Amlodipine Tablets IP | Each Film Coated Tablet Contains: | angiotensin receptor blockers | |||
| Amlodipine Besylate | ||||||
| Eq. to Amlodipine | IP | 5 mg | ||||
| Losartan Potassium | IP | 50 mg | ||||
| Excipients | q. s. | |||||
| 254 | Losartan Potassium & hydrochlorothiazide Tablets IP | Each Film Coated Tablet Contains: | ||||
| Losartan Potassium | IP | 50 mg | angiotensin receptor blockers | |||
| Hydrochlorothiazide | IP | 12.5 mg | ||||
| Excipients | q. s. | |||||
| 255 | Ondansetron Tablets IP 4 mg | Each Film Coated Tablet Contains: | ||||
| Ondansetron Hcl | 5-HT3 receptor antagonists | |||||
| Eq. to Ondansertron | IP | 4 mg | ||||
| Excipients | q. s. | |||||
| 256 | Ondansetron Tablets IP 8 mg | Each Film Coated Tablet Contains: | 5-HT3 receptor antagonists | |||
| Ondansetron Hcl | ||||||
| Eq. to Ondansertron | IP | 8 mg | ||||
| Excipients | q. s. | |||||
| 257 | Pantaprazole & Domperidone Tablets | Each enteric Coated Tablet contains: | ||||
| Pantaprazole Sodium Sesquihydrate | proton pump inhibitors | |||||
| Eq. to Pantaprazole | IP | 40 mg | ||||
| Domperidone | IP | 10 mg | ||||
| Excipients | q. s. | |||||
| 258 | Pantaprazole & Domperidone Tablets | Each enteric Coated Tablet contains: | proton pump inhibitors | |||
| Pantaprazole Sodium Sesquihydrate | ||||||
| Eq. to Pantaprazole | IP | 20 mg | ||||
| Domperidone | IP | 10 mg | ||||
| Excipients | q. s. | |||||
| 259 | Pantaprazole Tablets IP 20 mg | Each enteric Coated Tablet contains: | proton pump inhibitors | |||
| Pantaprazole Sodium Sesquihydrate | ||||||
| Eq. to Pantaprazole | IP | 20 mg | ||||
| Excipients | q. s. | |||||
| 260 | Prochlorperazine Maleate Tablets IP 5 mg | Each Uncoated Tablet Contains: | phenothiazines. | |||
| Prochlorperazine Maleate | IP | 5 mg | ||||
| Excipients | q. s. | |||||
| 261 | Quinine Sulphate Tablets IP 100 mg | Each Film Coated Tablet Contains: | ||||
| Quinine Sulphate | IP | 100 mg | antimalarials. | |||
| Excipients | q. s. | |||||
| 262 | Quinine Sulphate Tablets IP 300 mg | Each Film Coated Tablet Contains: | antimalarials. | |||
| Quinine Sulphate | IP | 300 mg | ||||
| Excipients | q. s. | |||||
| 263 | Rabeprazole Tablets IP 20 mg | Each enteric Coated Tablet contains: | Proton-pump inhibitor | |||
| Rabeprazole Sodium | IP | 20 mg | ||||
| Excipients | q. s. | |||||
| 264 | Ranitidine & Domperidone Tablets | Each Film Coated Tablet Contains: | ||||
| Ranitidine Hydrochloride | Proton-pump inhibitor | |||||
| Eq. to Ranitidine | IP | 150 mg | ||||
| Domperidone | IP | 10 mg | ||||
| Excipients | q. s. | |||||
| 265 | Talmisartan & AmlodipineTablets IP | Each Uncoated Tablet Contains: | hypertension | |||
| Telmisartan | IP | 40 mg | ||||
| Amlodipine Besylate | ||||||
| Eq. to Amlodipine | IP | 5 mg | ||||
| Excipients | q. s. | |||||
| 267 | Talmisartan & AmlodipineTablets IP | Each Uncoated bilayered Tablet Contains: | hypertension | |||
| Telmisartan | IP | 40 mg | ||||
| Hydrochlothiazide | IP | 12.5 mg | ||||
| Excipients | q. s. | |||||
| 268 | Telmisartan &Hydrochlorthiazide Tablets IP | Each Uncoated bilayered Tablet Contains: | ||||
| Telmisartan | IP | 80 mg | hypertension | |||
| Hydrochlothiazide | IP | 12.5 mg | ||||
| Excipients | q. s. | |||||
| 269 | Mefenamic Acid & Drotaverine hydrochloride Tablets | Each Film Coated Tablet Contains: | non-steroidal anti-inflammatory drug (NSAID) | |||
| Mefenamic Acid | IP | 250 mg | ||||
| Drotaverine hydrochloride | IP | 80 mg | ||||
| Excipients | q. s. | |||||
| 270 | Etoricoxib Tablets IP 60 mg | Each Film Coated Tablet Contains: | ||||
| Etoricoxib | IP | 60 mg | non-steroidal anti-inflammatory drugs (NSAIDs) | |||
| Excipients | q. s. | |||||
| 271 | Etoricoxib Tablets IP 120 mg | Each Film Coated Tablet Contains: | ||||
| Etoricoxib | IP | 120 mg | non-steroidal anti-inflammatory drugs (NSAIDs) | |||
| Excipients | q. s. | |||||
| 272 | Voglibose, Glimepiride & Metformin hydrochloride (Sustained Release) Tablets | Each Uncoated bilayered Tablet Contains: | ||||
| Voglibose | IP | 0.2 mg | biguanides | |||
| Glimepiride | IP | 2 mg | ||||
| Metformin hydrochloride | IP | 500 mg | ||||
| (As Sustained Release) | ||||||
| Excipients | q. s. | |||||
| 273 | Norfloxacin & Tinidazole Tablets | Each film coated Tablet Contains: | ||||
| Norfloxacin | IP | 400 mg | anti-bacterial | |||
| Tinidazole | IP | 600 mg | ||||
| Excipients | q. s. | |||||
| 274 | Pantoprazole Gastro-resistant Tablets IP 20 mg | Each Gastro-resistant Tablets Contains: | pront-pump inhibitor | |||
| Pantaprazole Sodium Sesquihydrate | ||||||
| Eq. to Pantoprazole | IP | |||||
| Excipients | ||||||
| 20 mg | ||||||
| q. s. | ||||||
| 275 | Diclofenac Potassium, Paracetamol & Serratiopeptidase Tablets | Each film coated Tablet Contains: | (non-steroidal anti-inflammatory drugs) | |||
| Diclofenac Potassium | BP | 50 mg | ||||
| Paracetamol | IP | 325 mg | ||||
| Serratiopeptidase | IP | 15 mg | ||||
| (As 30,000 enzymatic units of Serratiopeptidase) | ||||||
| Excipients | q. s. | |||||
| Colour: Sunset Yellow Lake | ||||||
| 276 | Tranexamic Acid Tablets | Each film coated Tablet Contains: | antifibrinolytics | |||
| Tranexamic Acid | IP | 500 mg | ||||
| Excipients | q. s. | |||||
| 277 | Paracetamol, Levocetirizine hydrochloride, Dextromethorphan hydrochloride, phenylephrine hydrochloride & Caffeiene Tablets | Each Uncoated Tablet Contains: | ||||
| Paracetamol | IP | 325 mg | antiallergic | |||
| Levocetirizine hydrochloride | IP | 5 mg | ||||
| Dextromethorphan hydrochloride | IP | 5 mg | ||||
| Phenylephrine hydrochloride | IP | 5 mg | ||||
| Caffeiene Anhydrous | IP | 30 mg | ||||
| Excipients | q. s. | |||||
| 278 | Nimesulide, Paracetamol & Serratiopeptidase Tablets | Each Film coated Tablet Contains: | anti-inflammatory drug (NSAID) and Paracetamol is an antipyretic (fever reducer) | |||
| Nimesulide | ||||||
| Paracetamol | BP | 100 mg | ||||
| Serratiopeptidase (Enteric Coated) | IP | 325 mg | ||||
| (As 30,000 enzymatic units of Serratiopeptidase) | IP | 15 mg | ||||
| Excipients | ||||||
| q. s. | ||||||
| 279 | Nimesulide,phenylephrine hydrochloride, Cetirizine hydrochloride & Caffeiene Tablets | Each Uncoated Tablet Contains: | ||||
| Nimesulide | IP | 100 mg | analgesic & anti-allegric | |||
| Cetirizine hydrochloride | IP | 5 mg | ||||
| Phenylephrine hydrochloride | IP | 10 mg | ||||
| Caffeine Anhydrous | IP | 30 mg | ||||
| Excipients | q. s. | |||||
| 280 | Aceclofenac, Paracetamol, Cetirizine, Phenylephrine Hcl & Caffeiene Tablets | Each Uncoated Tablet Contains: | ||||
| Aceclofenac | IP | 100 mg | ||||
| Paracetamol | IP | 325 mg | ||||
| Cetirizine hydrochloride | IP | 10 mg | anti-pyretic and anti-allegric | |||
| Phenylephrine hydrochloride | IP | 5 mg | ||||
| Caffeine Anhydrous | IP | 25 mg | ||||
| Excipients | q. s. | |||||
| 281 | Paracetamol, Levocetirizine hydrochloride, Phenylephrine hydrochloride, Caffeine Tablets | Each Film coated Tablet Contains: | ||||
| Paracetamol | anti-pyretic and anti-allegric | |||||
| Levocetirizine hydrochloride | IP | 325 mg | ||||
| Phenylephrine hydrochloride | IP | 5 mg | ||||
| Caffeine Anhydrous | IP | 10 mg | ||||
| Excipients | IP | 30 mg | ||||
| q. s. | ||||||
| 282 | Paracetamol, Phenylephrine hydrochloride, Chlorpheniramine Maleate & Caffeine Tablets | Each Film coated Tablet Contains: | ||||
| Paracetamol | anti-pyretic and anti-allegric | |||||
| Chlorpheniramine Maleate | IP | 325 mg | ||||
| Phenylephrine hydrochloride | IP | 2 mg | ||||
| Caffeine Anhydrous | IP | 10 mg | ||||
| Excipients | IP | 30 mg | ||||
| q. s. | ||||||
| 283 | Levocetirizine & Ambroxol hydrochloride Sustained Release Tablets | Each Film coated Tablet Contains: | ||||
| Levocetirizine Dihydrochloride | anti-allegric | |||||
| Ambroxol hydrochloride (In Sustained release form) | IP | 5 mg | ||||
| Excipients | IP | 75 mg | ||||
| q. s. | ||||||
| 284 | Diclofenac Sodium, Paracetamol Tablets | Each Uncoated Tablet Contains: | anti-inflammatory drug | |||
| Diclofenac Sodium | IP | 50 mg | ||||
| Paracetamol | IP | 325 mg | ||||
| Excipients | q. s. | |||||
| 285 | Bromhexine Hcl, Guaiphenesin, Chlorpheniramine Maleate, Phenylphrine Hcl& Paracetamol Tablets | Each Film coated Tablet Contains: | ||||
| Bromhexine hydrochloride | expectorants | |||||
| Guaiphenesin | IP | 4 mg | ||||
| Chlorpheniramine Maleate | IP | 50 mg | ||||
| Phenylphrine hydrochloride | IP | 4 mg | ||||
| Paracetamol | IP | 5 mg | ||||
| Excipients | IP | 325 mg | ||||
| q. s. | ||||||
| 286 | Etoricoxib & Thiocolchicoside Tablets | Each film coated Tablet Contains: | non-steroidal anti-inflammatory drugs (NSAIDs) | |||
| Etoricoxib | IP | 60 mg | ||||
| Thiocolchicoside | IP | 4 mg | ||||
| Excipients | q. s. | |||||
| 287 | Ketoconazole Tablets IP 200 mg | Each Uncoated Tablet Contains: | antifungals. | |||
| Ketoconazole | IP | 200 mg | ||||
| Excipients | q. s. | |||||
| 288 | Glimepiride & Metformin Sustained Release Tablets IP | Each Film coated Tablet Contains: | ||||
| Glimepiride | sulfonylureas | |||||
| Metformin hydrochloride | IP | 1 mg | ||||
| (Sustained Release) | IP | 1000 mg | ||||
| Excipients | q. s. | |||||
| 289 | Calcium with Vitamin D3 Tablets | Each Uncoated Tablets Contains: | ||||
| Calcium Carbonate (from an organic source oyster shell) | vitamin | |||||
| Eq. to elemental calcium | 1.25 gm | |||||
| Vtamin D3 | 500 mg | |||||
| Excipients | 250 IU | |||||
| q. s. | ||||||
| 290 | Diclofenac Potassium, Paracetamol & Chlorzoxazone Tablets | Each Film coated Tablet Contains: | ||||
| Diclofenac Potassium | anti-inflammatory drugs | |||||
| Paracetamol | BP | 50 mg | ||||
| Chlorzoxazone | IP | 325 mg | ||||
| Excipients | IP | 250 mg | ||||
| q. s. | ||||||
| 291 | Aceclofenac, Paracetamol & Chlorzoxazone Tablets | Each Film coated Tablet Contains: | ||||
| Aceclofenac | anti-inflammatory | |||||
| Paracetamol | IP | 100 mg | ||||
| Chlorzoxazone | IP | 325 mg | ||||
| Excipients | IP | 250 mg | ||||
| q. s. | ||||||
| 292 | Norfloxacin, Metronidazole & Simethicone Suspension | Each 5 ml contains: | ||||
| Norfloxacin | IP | 100 mg | quinolone antibiotics. | |||
| Metronidazole Benzoate | ||||||
| Eq. to Metronidazole | IP | 120 mg | ||||
| Simethicone | IP | 10 mg | ||||
| In a Flavoured Syrup base | q. s. | |||||
| Colour: Tartrazine | ||||||
| 293 | Azithromycin tablets | Each Film coated Tablet Contains: | macrolide antibiotics. | |||
| Azithromycin | USP | |||||
| (As Azithromycin Dihydrate) | ||||||
| Excipients | 250 mg | |||||
| Colour: Titanium Dioxide | ||||||
| q.s. | ||||||
| 294 | Azithromycin tablets | Each Film coated Tablet Contains: | ||||
| Azithromycin | macrolide antibiotics. | |||||
| (As Azithromycin Dihydrate) | USP | 500 mg | ||||
| Excipients | ||||||
| Colour: Titanium Dioxide | q. s. | |||||
| 295 | Levofloxacin Tablets USP 250 mg | Each Film Coated Tablet Contains: | quinolone antibiotics | |||
| Levofloxacin hemi-hydrate | ||||||
| Eq. to Levofloxacin | USP | 250 mg | ||||
| Excipients | q. s. | |||||
| 296 | Levofloxacin Tablets USP 500 mg | Each Film Coated Tablet Contains: | ||||
| Levofloxacin hemi-hydrate | quinolone antibiotics | |||||
| Eq. to Levofloxacin | USP | 500 mg | ||||
| Excipients | q. s. | |||||
| 297 | Ciprofloxacin Tablets USP 250 mg | Each Film Coated Tablet Contains: | ||||
| Ciprofloxacin hydrochloride | ||||||
| Eq. to Ciprofloxacin | USP | 250 mg | Anti-bacterial | |||
| Excipients | q. s. | |||||
| 298 | Ciprofloxacin Tablets USP 500 mg | Each Film Coated Tablet Contains: | ||||
| Ciprofloxacin hydrochloride | Anti-bacterial | |||||
| Eq. to Ciprofloxacin | USP | 500 mg | ||||
| Excipients | q. s. | |||||
| 299 | Diclofenac Potassium Tablets USP 50 mg | Each Tablet Contains: | ||||
| Diclofenac Potassium | USP | 50 mg | anti-inflammatory drug | |||
| Excipients | ||||||
| Colour: Sunset Yellow FCF | q. s. | |||||
| 300 | Rosuvastatin Tablets USP 10 mg | Each Film coated Tablet Contains: | Statin | |||
| Rosuvastatin Calcium | ||||||
| Eq. to Rosuvastatin | USP | |||||
| 10 mg | ||||||
| 301 | Rosuvastatin Tablets USP 20 mg | Each Film coated Tablet Contains: | Statin | |||
| Rosuvastatin Calcium | ||||||
| Eq. to Rosuvastatin | USP | 20 mg | ||||
| 302 | Atorvastatin Calcium Tablets USP 20mg | Each Film coated Tablet Contains: | statins | |||
| Atorvastatin Calcium | ||||||
| Excipients | USP | 20 mg | ||||
| q. s. | ||||||
| 303 | Pregabalin Capsules 75 mg | Each Hard Gelatin Capsules Contains: | anticonvulsants | |||
| Pregabalin | USP | 75 mg | ||||
| 304 | Meloxicam Tablets | Each Tablet Contains: | anti-inflammatory drugs | |||
| Meloxicam | USP | 15 mg | ||||
| 305 | Metronidazole Tablets BP 500 mg | Each Hard Gelatin Capsules Contains: | antibiotic | |||
| Metronizole | ||||||
| Excipients | BP | 500 mg | ||||
| q. s. | ||||||
| 306 | Levocetirizine Hydrochloride & Montelukast Sodium Tablets | Each Film coated Tablet Contains: | ||||
| Levocetirizine Hydrochloride | USP | antihistamines | ||||
| Montelukast Sodium | USP | 5 mg | ||||
| Eq. to Montelukast | ||||||
| Excipients | 10 mg | |||||
| q. s. | ||||||
| 307 | Sildenafil Tablets | Each Hard Gelatin Capsules Contains: | ||||
| Sildenafil Ctrate | (PDE) inhibitors. | |||||
| Eq. to Sildenafil | USP | |||||
| 100 mg | ||||||
| 308 | Itopride Hydrochloride Tablets 50 mg | Each Film coated Tablet Contains: | propulsives | |||
| Itopride Hydrochloride | ||||||
| Excipients | 50 mg | |||||
| q. s. | ||||||
| 309 | Calcium & Cholecalciferol Tablets BP | Each Uncoated Tablets Contains: | ||||
| Calcium Carbonate | BP | 1.25 gm | vitamin D analogs. | |||
| Eq. to elemental calcium | 500 mg | |||||
| Cholecalciferol (Stabilised) | ||||||
| Eq. to Cholecalciferol | BP | 250 IU | ||||
| 310 | Aceclofenac & Paracetamol Tablets | Each Film Coated Tablet Contains: | ||||
| Aceclofenac | BP | 100 mg | antiinflammatory | |||
| Paracetamol | BP | 325 mg | ||||
| Excipients | q. s. | |||||
| Colour: Titanium Dioxide USP | ||||||
| 311 | Ascorbic Acid (vitamin C) & Zinc Chewable Tablets | Each Chewable Contains: | ||||
| Ascorbic acid | IP | 200 mg | Vitamin | |||
| Sodium Ascorbate IP 338 mg | ||||||
| Eq. to Ascorbic Acid | IP | 300 mg | ||||
| Zinc Citrate NF | ||||||
| Eq. to elemental Zinc | 5 mg | |||||
| Excipients | q. s. | |||||
| Colour: Sunset Yellow Lake | ||||||
| 312 | Chlorhexidine Gluconate Solution & Cetrimide Antiseptic Liquid | Composition: | ||||
| Chlorhexidine Gluconate Solution | IP | 0.3%w/v | Anti-septic | |||
| Cetrimide | 0.6% w/v | |||||
| 313 | Chlorhexidine Gluconate, Cetrimide & Iso propyl Alcohol Concentration Solution | Composition: | ||||
| Chlorhexidine Gluconate Solution | IP | 7.5 %V/v | Anti-septic | |||
| Cetrimide | IP | 15 % w/v | ||||
| Iso propyl Alcohol | 7.5% v/v | |||||
| 314 | Spironolactone Tablets IP | Each Uncoated Tablets Contains: | ||||
| Spironolactone | IP | 100 mg | aldosterone receptor antagonists | |||
| Excipients | q. s. | |||||
| 315 | Cilostazol Tablets IP | Each Uncoated Tablets Contains: | ||||
| Cilostazol | IP | 50 mg | antiplatelet | |||
| Excipients | q. s. | |||||
| 316 | Cilostazol Tablets IP | Each Uncoated Tablets Contains: | ||||
| Cilostazol | IP | 100 mg | antiplatelet | |||
| Excipients | q. s. | |||||
| 317 | Tadalafil Tablets IP | Each Uncoated Tablets Contains: | ||||
| Tadalafil | IP | 5 mg | phosphodiesterase type 5 (PDE5) inhibitors | |||
| Excipients | q. s. | |||||
| 318 | Tadalafil Tablets IP | Each Uncoated Tablets Contains: | ||||
| Tadalafil | IP | 10 mg | phosphodiesterase type 5 (PDE5) inhibitors | |||
| Excipients | q. s. | |||||
| 319 | Aripiprazole Tablets IP | Each Uncoated Tablets Contains: | ||||
| Aripiprazole | IP | 10 mg | atypical antipsychotics | |||
| Excipients | q. s. | |||||
| 320 | Aripiprazole Tablets IP | Each Uncoated Tablets Contains: | ||||
| Aripiprazole | IP | 15 mg | atypical antipsychotics | |||
| Excipients | q. s. | |||||
| 321 | Entecavir Tablets IP | Each Film Coated Tablets Contains: | ||||
| Entecavir | IP | 1 mg | nucleoside analogs. | |||
| Excipients | q. s. | |||||
| 322 | Entecavir Tablets IP | Each Film Coated Tablets Contains: | ||||
| Entecavir | IP | 0.5 mg | nucleoside analogs. | |||
| Excipients | q. s. | |||||
| 323 | Dnepezil hydrochloride Tablet IP | Each Film Coated Tablet Contains: | ||||
| Dnepezil hydrochloride | IP | 10 mg | cholinesterase inhibitors | |||
| Excipients | q. s. | |||||
| 324 | Labetalol Hydrochloride Tablets IP | Each Film Coated Tablet Contains: | beta blockers | |||
| Labetalol Hydrochloride | IP | 100 mg | ||||
| Excipients | q. s. | |||||
| 325 | Labetalol Hydrochloride Tablets IP | Each Film Coated Tablet Contains: | beta blockers | |||
| Labetalol Hydrochloride | IP | 200 mg | ||||
| Excipients | q. s. | |||||
| 326 | Colchicine Tablets IP | Each Uncoated Tablet Contains: | ||||
| Colchicine | IP | 0.5 mg | non-steroidal anti-inflammatory | |||
| Excipients | q. s. | |||||
| 327 | Olanzapine Tablets IP | Each Film Coated Tablet Contains: | Atypical antipsychotic | |||
| Olanzapine | IP | 10 mg | ||||
| Excipients | q. s. | |||||
| 328 | Pirfenidone Tablets | Each Film Coated Tablet Contains: | ||||
| Pirfenidone | IP | 200 mg | pyridones | |||
| Excipients | q. s. | |||||
| 329 | Spironolactone Tablets IP | Each Uncoated Tablets Contains: | ||||
| Spironolactone | IP | 25 mg | idiopathic pulmonary fibrosis | |||
| Excipients | q. s. | |||||
| 330 | Spironolactone Tablets IP | Each Uncoated Tablets Contains: | ||||
| Spironolactone | IP | 50 mg | idiopathic pulmonary fibrosis | |||
| Excipients | q. s. | |||||
| 331 | Cefixime dispersible tablets | Each uncoated dispersible tablet contains: | ||||
| Cefixime trihydrate | IP | |||||
| Eq.to Anhydrous cefixime | 100mg | cephalosporin antibiotics | ||||
| Excipients | q.s | |||||
| Colour:Approved colour usde | ||||||
| 332 | Cefixime tablets | Each filmcoated dispersible tablets contains: | ||||
| Cefixime Trihydrate | IP | 200mg | cephalosporin antibiotics | |||
| Eq.to Anhydrous cefixime | q.s | |||||
| Excipients | ||||||
| Colour:Approved colour usde | ||||||
| 333 | Cefixime dispersible tablets | Each uncoated dispersible tablet contains: | ||||
| Cefixime trihydrate | IP | 50mg | cephalosporin antibiotics | |||
| Eq.to Anhydrous cefixime | q.s | |||||
| Excipients | ||||||
| Colour:Approved colour usde | ||||||
| 334 | Cefixime & Ofloxacin tablets | Each filmcoated dispersible tablets contains: | ||||
| Cefixime trihydrate | IP | Anti-biotics | ||||
| Eq.to Anhydrous cefixime | 100mg | |||||
| Ofloxacin | IP | 100mg | ||||
| Excipients | ||||||
| Colour:Approved colour usde | ||||||
| 335 | Cefixime & Ofloxacin tablets | Each filmcoated dispersible tablets contains: | ||||
| Cefixime trihydrate | Anti-biotics | |||||
| Eq.to Anhydrous cefixime | IP | 200mg | ||||
| Ofloxacin | IP | 200mg | ||||
| Excipients | ||||||
| Colour:Approved colour usde | ||||||
| 336 | Cefpodoxime tablet | Each filmcoated dispersible tablets contains: | ||||
| Cefpodoxime proxetil | IP | 200mg | antibiotic | |||
| Eq.to Cefpodoxime | q.s | |||||
| Excipients | ||||||
| Colour:Approved colour usde | ||||||
| 337 | Cefpodoxime tablet | Each filmcoated dispersible tablets contains: | antibiotic | |||
| Cefpodoxime proxetil | IP | 100mg | ||||
| Eq.to Cefpodoxime | q.s | |||||
| Excipients | ||||||
| Colour:Approved colour usde | ||||||
| 338 | Cefpoloxime | Each uncoated dispersible tablet contains: | ||||
| Cefpodoxime proxetil | IP | 100mg | ||||
| Eq.to Cefpodoxime | q.s | |||||
| Excipients | ||||||
| Colour:Approved colour usde | ||||||
| 339 | Cefpodoxime dispersible tablets | Each uncoated dispersible tablet contains: | IP | 200mg | antibiotic | |
| Cefpodoxime proxetil | q.s | |||||
| Eq.to Cefpodoxime | ||||||
| Excipients | ||||||
| Colour:Approved colour usde | ||||||
| 340 | Cefpoloxime &Ofloxacin tablets | Each filmcoated dispersible tablets contains: | ||||
| Cefpodoxime proxetil | ||||||
| Eq.to Cefpodoxime | IP | 200mg | antibiotic | |||
| Ofloxacin | IP | 200mg | ||||
| Excipients | q.s | |||||
| Colour:Approved colour usde | ||||||
| 341 | Cefpodoxime &potassium clavulanate tablets | Each filmcoated dispersible tablets contains: | ||||
| Cefpodoxime proxetil | IP | 200mg | antibiotic | |||
| Eq.to Cefpodoxime | ||||||
| Potassium clavulanate | IP | 125mg | ||||
| Eq.to clavulanic Acid | ||||||
| 342 | Cefpodoxime &potassium clavulanate tablets | Each filmcoated dispersible tablets contains: | ||||
| Cefpodoxime proxetil | IP | 100mg | antibiotic | |||
| Eq.to Cefpodoxime | ||||||
| Potassium clavulanate | IP | 62.5mg | ||||
| Eq.to clavulanic Acid | ||||||
| 343 | Cefuroxime tablets | Each filmcoated dispersible tablets contains: | ||||
| Cefuroxime Axetil | IP | 250mg | cephalosporin antibiotics | |||
| Eq.to Cefuroxime | ||||||
| Excipient | ||||||
| Colour:Approved colour usde | ||||||
| 344 | Cefuroxime tablets | Each filmcoated dispersible tablets contains: | ||||
| Cefuroxime Axetil | IP | 500mg | cephalosporin antibiotics | |||
| Eq.to Cefuroxime | ||||||
| Excipients | ||||||
| Colour:Approved colour usde | ||||||
| 345 | Cefuroxime &potassium clavulanate acid tablets | Each filmcoated dispersible tablets contains: | ||||
| Cefuroxime Axetil | IP | 250mg | cephalosporin antibiotics | |||
| Eq.to Cefuroxime | ||||||
| Potassium clavulanate | IP | 125mg | ||||
| Eq.to clavulanic Acid | ||||||
| Excipients | ||||||
| Colour:Approved colour usde | ||||||
| 346 | Cefuroxime &potassium clavulanate acid tablets | Each filmcoated dispersible tablets contains: | ||||
| Cefuroxime Axetil | IP | 500mg | antibiotic | |||
| Eq.to Cefuroxime | ||||||
| Potassium clavulanate | IP | 125mg | ||||
| Eq.to clavulanic Acid | ||||||
| Excipients | ||||||
| Colour:Approved colour usde | ||||||
| 347 | Cefadroxil tablets | Each filmcoated dispersible tablets contains: | ||||
| Cefadroxil | IP | 500mg | antibiotic | |||
| Eq.to Anhydrous cefadroxil | ||||||
| Excipients | ||||||
| Colour:Approved colour usde | ||||||
| 348 | Sultamicillin tablets | Each film coated tablets contains: | ||||
| Sultamicillin (as tosylate dihydrate) | BP | 375mg | antibiotic | |||
| Eq.to sulbactum 147 mg & ampicillin 220mg ) | ||||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 349 | Cephalexin tablets | Each film coated tablets contains: | ||||
| Contains: | IP | 250mg | cephalosporin antibiotics | |||
| Eq. to Anhydrous Cephalexin | ||||||
| Excipients | ||||||
| Colour :Approved colour used | ||||||
| 350 | Amoxycillin dispersible tablets | Each uncoated dispersible tablet contains: | antibiotic | |||
| Amoxycillin trihydrate | IP | 125mg | ||||
| Eq.to Amoxycillin | q.s | |||||
| Excipients | ||||||
| Colour:Approved colour usde | ||||||
| 351 | Amoxycillin &Potassium clavulanate acid tablet | Each filmcoated dispersible tablets contains: | ||||
| Amoxycillin trihydrate | IP | 500mg | antibiotic | |||
| Eq.to Amoxycillin | ||||||
| Potassium clavulanate | IP | 125mg | ||||
| Eq.to clavulanic Acid | q.s | |||||
| Colour :Approved colour used | ||||||
| 352 | Amoxycillin &Potassium clavulanate acid tablet | Each filmcoated dispersible tablets contains: | ||||
| Amoxycillin trihydrate | IP | 250mg | antibiotic | |||
| Eq.to Amoxycillin | ||||||
| Potassium clavulanate | IP | 125mg | ||||
| Eq.to clavulanic Acid | q.s | |||||
| Colour:titanium dioxide IP | ||||||
| 353 | Amoxycillin &Potassium clavulanate acid tablet | Each filmcoated dispersible tablets contains: | ||||
| Amoxycillin trihydrate | IP | 875mg | antibiotic | |||
| Eq.to Amoxycillin | ||||||
| Potassium clavulanate | IP | 125mg | ||||
| Eq.to clavulanic Acid | q.s | |||||
| Colour:titanium dioxide IP | ||||||
| 354 | Amoxycillin &Potassium clavulanate acid dispersible tablet | Each uncoated dispersible tablet contains: | ||||
| Amoxycillin trihydrate | IP | 200mg | antibiotic | |||
| Eq.to Amoxycillin | ||||||
| Potassium clavulanate | IP | 28.5mg | ||||
| Eq. to Clavulanic acid | q.s | |||||
| Colour : Titanium Dioxide IP | ||||||
| 355 | Aceclofenac with Paracetamol tablets | Each film coated tablets contains: | ||||
| Aceclofenac………. | IP | 100mg | anti-pyretic and analgesic | |||
| Paracetamol……….. | IP | 325mg | ||||
| Excipients………. | ||||||
| Approved colour…..Titanium di oxide | ||||||
| 356 | Aceclofenac with Paracetamol tablets | Each uncoated dispersible tablet contains: | ||||
| Aceclofenac………. | IP | 100mg | anti-pyretic and analgesic | |||
| Paracetamol……….. | IP | 325mg | ||||
| Excipients…….. | q.s | |||||
| Approved colour…..Titanium di oxide Added | ||||||
| 357 | ofloxacin tablets | Each film coated tablets contains: | ||||
| ofloxacin…… | IP | 200mg | Anti-bacterial | |||
| Excipients………. | q.s | |||||
| Approved colour Titanium dioxide | ||||||
| 358 | Azithromycin tablets | Each film coated tablets contains: | ||||
| Azithromycin….. | IP | 500mg | macrolide antibiotics | |||
| Excipients…….. | q.s | |||||
| Approved colour……sunset Yellow | ||||||
| 359 | Azithromycin tablets | Each film coated tablets contains: | ||||
| Azithromycin….. | IP | 250mg | macrolide antibiotics | |||
| Excipients…… | q.s | |||||
| Approved colour……….sunset yellow | ||||||
| 360 | Livocetrizine & Montelukast tablets | Each film coated tablets contains: | ||||
| Livocetrizine | Anti-allgeric | |||||
| Hydrochloride……….. | IP | 5mg | ||||
| Montelukast…………… | IP | 10mg | ||||
| Excipients……………….. | q.s | |||||
| Approved colour……….Titanium di oxide | ||||||
| 361 | Paracetamol tablets | Each film coated tablets contains: | ||||
| Paracetamol……….. | IP | 500mg | antipyretic and analgesic | |||
| Excipients…………… | q.s | |||||
| Approved colour…….Ttitanium di oxide | ||||||
| 362 | Paracetamol tablets | Each film coated tablets contains: | ||||
| Paracetamol……….. | IP | 650mg | antipyretic and analgesic | |||
| Excipients…………… | q.s | |||||
| Approved colour…….Ttitanium di oxide | ||||||
| 363 | Ramipril tablets | Each uncoated dispersible tablet contains: | ACE inhibitors | |||
| Ramipril | BP | 5mg | ||||
| Excipients | q.s | |||||
| 364 | Ramipril tablets | Each uncoated dispersible tablet contains: | ||||
| Ramipril | BP | 10mg | ||||
| Excipients | q.s | |||||
| 365 | Telmisartan tablets | Each uncoated dispersible tablet contains: | ||||
| Telmisartan | IP | 80mg | Hypertension | |||
| Excipients | q.s | |||||
| 366 | Telmisartan tablets | Each uncoated dispersible tablet contains: | ||||
| Telmisartan | IP | 40mg | Hypertension | |||
| Excipients | q.s | |||||
| 367 | Glimepiride &metformin hydrochloride(sustained release tablets) | Each uncoated dispersible tablet contains: | ||||
| Glimepiride | IP | 2mg | sulfonylureas | |||
| metformin HCL (as sustained release form ) | IP | 500mg | ||||
| Excipients | q.s | |||||
| 368 | Ascorbic acid tablets 100 mg | Each uncoated chewable tablets contains: | ||||
| Ascorbic acid | IP | 100 mg | Vitamin | |||
| Excipients | q.s | |||||
| Approved colour used in tablets | ||||||
| 369 | Luliconazole cream | Composition | ||||
| Luliconazole | IP | 1.0%W/W | antifungal | |||
| Preservetive | ||||||
| Benzyl alcohol | IP | 1.0%W/W | ||||
| In a cream base | ||||||
| 370 | Rabeprazole tablets | Each enteric coated tablets contains: | proton pump inhibitors (PPIs). | |||
| Rabeprazole sodium | IP | 20mg | ||||
| Approved colour used | q.s | |||||
| Excipients | ||||||
| 371 | Levocetirizine dihydrochloride tablets | Each film coated tablets contains: | Anti-allgeric | |||
| Levocetirizine dihydrochloride | IP | 5mg | ||||
| Excipients | q.s | |||||
| colour:Approved colour usde in tablets | ||||||
| 372 | Nimesulide tablets | Each uncoated dispersible tablet contains: | analgesic | |||
| Nimesulide | IP | 100mg | ||||
| Excipients | q.s | |||||
| 373 | Cinnarizine & Domperidone Maleate tablets | Each uncoated dispersible tablet contains: | ||||
| Cinnarizine | IP | 20mg | antiemetic | |||
| Domperidone Maleate | IP | 15mg | ||||
| Eq. to Domperidone | q.s | |||||
| Excipients | ||||||
| 374 | Telmisartan & Hydrochlorothaizide tablets | Each uncoated Bilayered tablets contains: | Hypertension | |||
| Telmisartan | IP | 40mg | ||||
| Hydrochlorothaizide | IP | 12.5mg | ||||
| Excipients | q.s | |||||
| Colour :Approved colour used in tablets | ||||||
| 375 | Etoricoxib tablets | Each film coated tablets contains: | anti-inflammatory drugs | |||
| Etoricoxib | IP | 90mg | ||||
| Excipients | q.s | |||||
| Approved colour used in tablets | ||||||
| 376 | Glimepiride tablets | Each uncotsd tablets contains: | ||||
| Glimepiride | IP | 1mg | sulfonylureas | |||
| Approved colour used in tablets | q.s | |||||
| 377 | Glimepiride tablets | Each uncotsd tablets contains: | ||||
| Glimepiride | IP | 2mg | sulfonylureas | |||
| Approved colour used in tablets | q.s | |||||
| 378 | Linezolid tablets | Each film coated tablets contains: | ||||
| Linezolid | IP | 600mg | antibiotic | |||
| Excipients | q.s | |||||
| Approved colour used in tablets | ||||||
| 379 | Glicazide tablets | Each uncotsd tablets contains: | sulfonylurea | |||
| Glicazide | IP | 80mg | ||||
| Excipients | q.s | |||||
| 380 | Folic acid tablets | Each uncotsd tablets contains: | ||||
| Folic acid | IP | 5mg | Vitamins, Water-Soluble. | |||
| Excipients | q.s | |||||
| 381 | Losartan tablets | Each film coated tablets contains: | ||||
| Losertan potassium | IP | 50mg | hypertension | |||
| Excipients | q.s | |||||
| Colour: Approved colour used | ||||||
| 382 | Paracetamol,Phenylephrine Hydrochloride, Ceffeine & Diphenhydramine hydrochoride Tablets | Each uncoated tablets contains: | ||||
| Paracetamol | IP | 125mg | antiallergic | |||
| Phenylephrine hydrochloride | IP | |||||
| Caffeine (Anhydrous) | IP | 2.5mg | ||||
| Diphenhydramine hydrochoride | IP | 2.5mg | ||||
| Excipients | q.s | |||||
| Approved colour used in tablets | ||||||
| 383 | Tranexamic acid &Mefenamic acid tablets | Each film coated tablets contains: | antifibrinolytics. | |||
| Tranexamic acid | IP | 500mg | ||||
| Mefenamic acid | IP | 250mg | ||||
| Excipients | q.s | |||||
| Approved colour used in tablets | ||||||
| 384 | Nimesulide, Phenylephrine hydrochloride & levocetirizine Dihydrochloride Tablets | Each uncoated tablets contains: | anti-inflammatory | |||
| Nimesulide | BP | 100mg | ||||
| Phenylephrine hydrochloride | IP | 5mg | ||||
| levocetirizine Dihydrochloride | IP | 5mg | ||||
| Excipients | q.s | |||||
| Colour:Quinoline yellow WS | ||||||
| 385 | Metformin hydrochloride prolongd release and glimepiride tablets IP | Each uncoated tablets contains: | ||||
| Glimepiride……………. | IP | 1mg | antidiabetic | |||
| Metformin HCL ( sustained release )……………….. | IP | 500mg | ||||
| Excipients…………………… | q.s | |||||
| Approved colour added | ||||||
| 386 | Voglibose & Metformin hydrochloride (sustainrd release) tablets | Each film coated tablets contains: | Alpha glucosidase inhibitors | |||
| Voglibose………. | IP | 0.3mg | ||||
| Metformin HCL ( sustained release )……………….. | IP | 500mg | ||||
| Excipients…………………… | q.s | |||||
| 387 | Voglibose & Metformin hydrochloride (sustainrd release) tablets | Each film coated tablets contains: | ||||
| Voglibose………. | IP | 0.2mg | Alpha glucosidase inhibitors | |||
| Metformin HCL ( sustained release )……………….. | IP | 500mg | ||||
| Excipients…………………… | q.s | |||||
| Approved colour added | ||||||
| 388 | Carbonyl iron, folic acid, vitamin B12 & zinc sulphate tablets | Each film coated tablets contains: | ||||
| Carbonyl iron | IP | 100mg | Vitamins | |||
| Eq.to elemental iron | ||||||
| Folic acid | IP | 1.5mg | ||||
| Vitamin B12 | IP | 15mg | ||||
| Zinc sulphate monohydrate | IP | 22.5mg | ||||
| Excipients | q.s | |||||
| Approbved colour used in tablets | ||||||
| 389 | Thiamine hydrochloride tablets 100 mg | Each film coated tablets contains: | ||||
| Thiamine hydrochloride | IP | 100mg | Vitamins b1 | |||
| Excipients | q.s | |||||
| Approbved colour used in tablets | ||||||
| 390 | Ferrous Ascorbate, Folic Acid, Cyanocobalamin & Zinc Sulphate Tablets | Each film coated tablets contains: | ||||
| Ferrous ascorbate | ||||||
| Eq.to elemental iron | IP | 100mg | Vitamins | |||
| Folic acid | IP | 1.5mg | ||||
| Cyanocobalamin triturate | ||||||
| Eq.to Cyanocobalamin | IP | 7.5mg | ||||
| Zinc sulphate monohydrate | IP | 22.5mg | ||||
| Eq.to elemental zinc | ||||||
| Excipients | q.s | |||||
| Approbved colour used in tablets | ||||||
| 391 | Aceclofenac Sustained Release Tablets IP | Each uncoated Sustained release tablet contains: | anti-inflammatory drugs | |||
| Aceclofenac | IP | 200mg | ||||
| Excipients | ||||||
| 392 | Aceclofenac & Diacerin Tablet | Each filmcoated tablet contains: | ||||
| Aceclofenac | IP | 100mg | anti-inflammatory drugs | |||
| Diacerin | IP | 80mg | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 393 | Doxofylline Tablets IP | Each uncoated tablet contain: | ||||
| Doxofyllin | IP | 400mg | xanthine derivative drug (asthma) | |||
| Excipients | ||||||
| 394 | Methylcobalamin Tablet IP | Each filmcoated tablet contains: | ||||
| Methylcobalamin | IP | 500mcg | Vitamins | |||
| Excipients | ||||||
| 395 | Dosulepin tablets IP | Each filmcoated tablet contains: | ||||
| Dosulepin Hydrochloride | IP | 100mg | ||||
| Excipients | ||||||
| 396 | Ferrous Ascorbate, folic acid, Zinc Sulphate & cyanocobalamin tablets | Each filmcoated tablet contains: | Vitamins | |||
| Ferrous Ascorbate | ||||||
| Eq. to Elemental Iron | 100mg | |||||
| folic acid | IP | 1.5mg | ||||
| Zinc sulphate Monohydrate | IP | 61.8mg | ||||
| Eq. to. Elemental Zinc | ||||||
| cyanocobalamin | 22.5mg | |||||
| Excipients | 15 mcg | |||||
| Colour: Approved colour used | ||||||
| 397 | Drotravarine & Aceclofenac Tablets | Each filmcoated tablet contains: | ||||
| Drotravarine hydrochloride | IP | anti-inflammatory drug | ||||
| Eq. to.Drotravarine | 50mg | |||||
| Aceclofenac | IP | 100mg | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 398 | Fexofinadine & Montelukast Chewable Tablets | Each uncoated tablet contain: | ||||
| Fexofinadine HCL | IP | 120mg | antihistamines | |||
| Montelukast Sodium | IP | |||||
| Eq. to. Montelukast | 10mg | |||||
| 399 | Voglibose & Metformin HCL Tablets | Each uncoated tablet contain: | ||||
| Voglibose | IP | 0.2mg | antidiabetic | |||
| Metformin HCL | IP | 500mg | ||||
| Excipients | ||||||
| 400 | Calcium citrate Maleate, Vitamin D3 With folic Acid tablets | Each uncoated tablet contain: | ||||
| Calcium citrate Maleate | ||||||
| Eq. to. Elemental calcium | 250mg | Vitamins | ||||
| Vitamin D3 | IP | 100IU | ||||
| folic Acid | IP | 50mcg | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 401 | Diclofenac sodium and Serratiopeptidase Tablets | Each enteric coated tablet contain: | ||||
| Diclofenac sodium | IP | 50mg | NSAID | |||
| Serratiopeptidase | IP | 10mg | ||||
| Excipients | q.s | |||||
| Colour: Approved colour used | ||||||
| 402 | Calcium citrate , Calcitriol, Zinc sulphate monohydrate & Manganese Tablets | Each filmcoated tablet contains: | ||||
| Calcium citrate | USP | 1000mcg | (osteoporosis), weak bones (osteomalacia/rickets) | |||
| Calcitriol | BP | 0.25mcg | ||||
| Zinc sulphate monohydrate | ||||||
| Eq. to. Elemental Zinc | 7.5mg | |||||
| Manganese sulphate | IP | |||||
| Eq. to. Manganese | 40mg | |||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 403 | Doxofylline Tablets IP | Each filmcoated tablet contains: | xanthine derivative drug | |||
| Doxofylline | IP | 400mg | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 404 | Ciprofloxacin and Tinidazole Tablets | Each filmcoated tablet contains: | ||||
| Ciprofloxacin HCL | IP | antibiotics | ||||
| Eq. to. Ciprofloxaxin | 500mg | |||||
| Tinidazole | IP | 600mg | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 405 | Tranexamic Acid & Ethamsylate Tablets | Each filmcoated tablet contains: | anti-fibrinolytic agents' | |||
| Tranexamic Acid | BP | 250mg | ||||
| Ethamsylate | BP | 250mg | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 406 | Aceclofenac Tablet IP | Each filmcoated tablet contains: | ||||
| Aceclofenac | IP | 100mg | inflammatory | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 407 | Pantoprazole and Domperidone tablets | Each enteric coated tablet contain: | Proton- pump inhibitor | |||
| Pantoprazole sodium | IP | 40mg | ||||
| Eq. to. Pantaprozole | 10mg | |||||
| Domperidone | IP | |||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 408 | Doxofylline & Ambroxol HCL Tablets | Each filmcoated tablet contains: | ||||
| Doxofylline | IP | 400mg | xanthine derivative drug | |||
| Ambroxol HCL | IP | 30mg | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 409 | Ivermectin Tablets | Each uncoated tablet contain: | anthelmintics | |||
| Ivermectin | IP | 6mg | ||||
| Excipients | ||||||
| 410 | Ondansetron Orally Disentegratinf Tablets IP | Each Orally Disentegrating tablets contain: | ||||
| Ondansetron HCL | IP | serotonin 5-HT3 receptor antagonists | ||||
| Eq. to. Ondansetron | 4mg | |||||
| Excipients | ||||||
| 411 | Ezetimibe & Simvastatin Tablets | Each filmcoated tablet contains: | ||||
| Ezetimibe | IP | 10mg | statins | |||
| Simvastatin | IP | 20mg | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 412 | Nateglinide & Metformin HCL (SR) Tablets | Each uncoated tablet contain: | ||||
| Nateglinide | IP | 600mg | meglitinides | |||
| Metformin HCL | IP | 500mg | ||||
| As sustained release | ||||||
| Excipients | ||||||
| 413 | Nateglinide & Metformin HCL (SR) Tablets | Each uncoated tablet contain: | ||||
| Nateglinide | IP | 120mg | meglitinides | |||
| Metformin HCL | IP | 500mg | ||||
| As sustained release | ||||||
| Excipients | ||||||
| 414 | Thicolchicoside & Ketoprofen Tablet | Each filmcoated tablet contains: | ||||
| Thicolchicoside | IP | 4mg | NSAIDs. | |||
| Ketoprofen | IP | 50mg | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 415 | Thicolchicoside & Ketoprofen Tablet | Each filmcoated tablet contains: | ||||
| Thicolchicoside | IP | 8mg | NSAIDs. | |||
| Ketoprofen | IP | 100mg | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 416 | Hyoscine Butylbromide Tablets IP | Each filmcoated tablet contains: | ||||
| Hyoscine Butylbromide | IP | 10mg | anticholinergic drug | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 417 | Atorvastatin & Nicotinic Acid (ER) tablet | Each filmcoated tablet contains: | ||||
| Atorvastatin calcium | IP | antilipemic agents | ||||
| Eq. to atorvastatin | 10mg | |||||
| Nicotinic Acid | IP | 375mg | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 418 | Atorvastatin & Nicotinic Acid (ER) tablet | Each filmcoated tablet contains: | ||||
| Atorvastatin calcium | IP | antilipemic agents | ||||
| Eq. to atorvastatin | 10mg | |||||
| Nicotinic Acid | IP | 500mg | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 419 | Amlodipine Hydrochlorthazide Tablet | Each filmcoated tablet contains: | calcium channel blockers | |||
| Amlodipine Besylate | IP | |||||
| Eq. to.Amlodipine | 5mg | |||||
| Hydrochlorthazide | IP | 12.5mg | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 420 | Amlodipine Hydrochlorthazide Tablet | Each filmcoated tablet contains: | ||||
| Amlodipine Besylate | IP | calcium channel blockers | ||||
| Eq. to.Amlodipine | 2.5mg | |||||
| Hydrochlorthazide | IP | 12.5mg | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 421 | Cefpodoxime & ofloxacin Tablet | Each filmcoated tablet contains: | ||||
| Cefpodoxime proxetil | IP | cephalosporin antibiotics. | ||||
| Eq. to. Cefpodoxime | 200mg | |||||
| ofloxacin | IP | 200mg | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 422 | Aceclofenac & Thiocolchicoside Tablet | Each filmcoated tablet contains: | ||||
| Aceclofenac | IP | 100mg | anti-inflammatory drug (NSAID) | |||
| Thiocolchicoside | IP | 8mg | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 423 | Nimesulide Phenylephlephrine Hydrochloride, Levocetirizine Hydrochloride Tablets | Each uncoated tablet contains: | anti-inflammatory drug (NSAID) | |||
| Nimesulide | BP | 100mg | ||||
| Phenylephlephrine | IP | 5mg | ||||
| Hydrochloride | ||||||
| Levocetirizine Hydrochloride | IP | 5mg | ||||
| Excipients | ||||||
| 424 | Paracetamol, Phenylephrine Hydrochloride & caffeine Tablet | Each uncoated tablet contains: | ||||
| Paracetamol | IP | 500mg | ||||
| caffeine Anhydrous | IP | 32mg | Anti-allgeric | |||
| Phenylephrine Hydrochloride | IP | 10mg | ||||
| Excipients | ||||||
| 425 | Paracetamol, Phenylephrine Hydrochloride Diphenhydramine Hyrochloride Caffeine Tablet | Each uncoated tablet contains: | ||||
| Paracetamol | IP | 500mg | Anti-allgeric | |||
| Phenylephrine | IP | 5mg | ||||
| Hydrochloride Diphenhydramine Hyrochloride | IP | 25mg | ||||
| Caffeine | IP | 30mg | ||||
| Excipients | ||||||
| 426 | Lansoprazole orally Disintegration Tablet | Each uncoated tablet contains: | ||||
| Lansoprazole | IP | 30mg | proton pump inhibitors. | |||
| (as entric coated pellets) | ||||||
| Excipients | q.s | |||||
| 427 | Mefenamic Acid & Dicyclomine Hydrochloride Tablet IP | Each uncoated tablet contains: | ||||
| Mefenamic Acid | IP | 250mg | analgesic, anti-inflammatory | |||
| Dicyclomine Hydrochloride | IP | 10 mg | ||||
| Excipients | ||||||
| 428 | Paracetamol, Levocetirizine Hydrochloride & Phenylephrine Hydrochloride Tablet | Each uncoated tablet contains: | ||||
| Paracetamol | IP | 325mg | antiallergic | |||
| Levocetirizine Hydrochloride | IP | 5mg | ||||
| Phenylephrine Hydrochloride | IP | 5mg | ||||
| Excipients | ||||||
| 429 | Paracetamol , Phenylephrine Hydrochloride & Cetirizine Tablet | Each uncoated tablet contains: | ||||
| Paracetamol | IP | 500mg | Anti-allgeric | |||
| Phenylephrine Hydrochloride | IP | 10mg | ||||
| Cetirizine hydrochloride | IP | 5mg | ||||
| Excipients | ||||||
| 430 | Paracetamol , Phenylephrine Hydrochloride , Chlorpheniramines Maleate & Caffeine Tablet | Each uncoated tablet contains: | ||||
| Paracetamol | IP | 325mg | Anti-allgeric | |||
| Phenylephrine Hydrochloride | IP | 10mg | ||||
| Chlorpheniramines Maleate | IP | 2mg | ||||
| Caffeine | IP | 30mg | ||||
| Excipients | ||||||
| 431 | Paracetamol, levocetirizine Hydrochloride & Phenylephrine Hydrochloride Tablet | Each uncoated tablet contains: | ||||
| Paracetamol | IP | 500mg | Anti-allgeric | |||
| levocetirizine Hydrochloride | IP | 5mg | ||||
| Phenylephrine Hydrochloride | IP | 5mg | ||||
| Excipients | ||||||
| 432 | Trypsin Bromelain Rutoside Tablet | Each enteric coated tablet contain: | ||||
| Trypsin | IP | 96mg | anti-inflammatory | |||
| Bromelain | IP | 180mg | ||||
| Rutoside trihydrate | IP | 200mg | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 433 | Rifaximin Tablet | Each filmcoated tablet contains: | ||||
| Rifaximin PH Eur | 400mg | antibiotics | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 434 | Rifaximin Tablet | Each filmcoated tablet contains: | ||||
| Rifaximin PH Eur | 400mg | antibiotics | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 435 | Rifaximin Tablet | Each filmcoated tablet contains: | antibiotics | |||
| Rifaximin PH Eur | 550mg | |||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 436 | Clarithromycin Tablet IP | Each filmcoated tablet contains: | ||||
| Clarithromycin | IP | 500mg | Antibiotic | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 437 | Clarithromycin Tablet IP | Each filmcoated tablet contains: | ||||
| Clarithromycin | IP | 250mg | Antibiotic | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 438 | Etoricoxib Tablet IP | Each filmcoated tablet contains: | ||||
| Etoricoxib | IP | 60mg | anti-inflammatory drug. | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 439 | Etoricoxib Tablet IP | Each filmcoated tablet contains: | ||||
| Etoricoxib | IP | 90mg | anti-inflammatory drug. | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 440 | Albendazole Tablet | Each uncoated tablet contains: | ||||
| Albendazole | IP | 400mg | antihelmintics | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 441 | Citicoline& Piracitam Tablets | Each filmcoated tablet contains: | CDP-choline; cytidine 5'-diphosphocholine | |||
| Citicoline Sodium | IP | |||||
| Eq. to.Citicoline | 500mg | |||||
| piracitam | IP | 800mg | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 442 | Cefixime & Ornidazole Tablet | Each filmcoated tablet contains: | antibiotic | |||
| Cefixime Trihydrate | IP | |||||
| Eq. to Cefixime | 100mg | |||||
| Ornidazole | IP | 500mg | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 443 | Bromhexin HCL, Chlorpheniramine Maleate , Terbutaline Sulphate Tablets | Each uncoated tablet contains: | ||||
| Bromhexin HCL | IP | 16mg | 0 | |||
| Chlorpheniramine Maleate | IP | 4mg | ||||
| Terbutaline Sulphate | IP | 2.5mg | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 444 | Clopidogrel Tablet IP | Each filmcoated tablet contains: | ||||
| Clopidogrel Bisulphate | IP | Thienopyridine | ||||
| Eq. to.Clopidogrel | 75mg | |||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 445 | Clopidogrel & Aspirin Tablet IP | Each filmcoated tablet contains: | ||||
| Clopidogrel Bisulphate | IP | Thienopyridine | ||||
| Eq. to.Clopidogrel | 75mg | |||||
| Aspirin | IP | 75mg | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 446 | Clopidogrel & Aspirin Tablet IP | |||||
| Each filmcoated tablet contains: | Thienopyridine | |||||
| Clopidogrel Bisulphate | IP | |||||
| Eq. to.Clopidogrel | 75mg | |||||
| Aspirin | IP | 150mg | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 447 | Losartan Potassium & Hydrochlorothiazide Tablet IP | Each filmcoated tablet contains: | ||||
| Losartan Potassium | IP | 50mg | hypertension | |||
| Hydrochlorothiazide | IP | 212.5mg | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 448 | Losartan Potassium | Each filmcoated tablet contains: | ||||
| Losartan Potassium | IP | 50mg | hypertension | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 449 | Losartan Potassium | Each filmcoated tablet contains: | ||||
| Losartan Potassium | IP | 25mg | hypertension | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 450 | Paracetamiol Tablet IP | Each uncoated tablet contains: | ||||
| Paracetamiol | IP | 500mg | analgesics | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 451 | Paracetamiol Tablet IP | Each uncoated tablet contains: | ||||
| Paracetamiol | IP | 650mg | analgesics | |||
| Excipients | ||||||
| 452 | Paracetamol & Caffeine Tablet IP | Each uncoated tablet contains: | ||||
| Paracetamol | IP | 650mg | analgesic and antipyretic | |||
| Caffeine (Anhydrous) | IP | 25mg | ||||
| Excipients | q.s | |||||
| 453 | Paracetamol & Caffeine Tablet IP | Each uncoated tablet contains: | ||||
| Paracetamol | IP | 500mg | analgesic and antipyretic | |||
| Caffeine (Anhydrous) | IP | 25mg | ||||
| Excipients | q.s | |||||
| 454 | Folic Acid Tablets | Each uncoated tablet contains: | ||||
| Folic Acid | IP | 10mg | ||||
| Excipients | ||||||
| 455 | Folic Acid & Methylcobalamin Tablets | Each uncoated tablet contains: | ||||
| folic Acid | IP | 5mg | vitamin | |||
| Methylcobalamin | IP | 750mg | ||||
| Excipients | ||||||
| 456 | Paracetamol & Ibuprofen Tablet IP | Each uncoated tablet contains: | ||||
| Paracetamol | IP | 325mg | analgesic and antipyretic | |||
| Ibuprofen | IP | 400mg | ||||
| Excipients | ||||||
| 457 | Cholecalciferol chewable Tablet 60000 IU | Each uncoated tablet contains: | ||||
| Cholecalciferol | IP | 60000IU | vitamin | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 458 | Tadalafil Tablet | Each filmcoated tablet contains: | ||||
| Tadalafil | IP | 20mg | phosphodiesterase (PDE) inhibitors. | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 459 | Piracetam Tablet | Each filmcoated tablet contains: | ||||
| Piracetam | IP | 800mg | antipsychotic drugs | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 460 | Fluconazole Tablet | Each uncoated tablet contains: | Anti-fungal | |||
| Fluconazole | IP | 200mg | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 461 | Norfloxacin & Tinidazolre Tablet | Each filmcoated tablet contains: | ||||
| Norfloxacin | IP | 400mg | antibacterials. | |||
| Tinidazolre | IP | 600mg | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 462 | Primaquine Tablet IP | Each filmcoated tablet contains: | antimalarials. | |||
| Primaquine Phosphate | IP | |||||
| Eq. to. Primaquine | 7.5mg | |||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 463 | Primaquine Tablet IP | Each filmcoated tablet contains: | ||||
| Primaquine Phosphate | IP | |||||
| Eq. to. Primaquine | 15mg | antimalarials. | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 464 | Acyclovir Tablets | Each uncoated tablet contains: | ||||
| Acyclovir | IP | 200mg | Anti-viral | |||
| Excipients | ||||||
| 465 | Acyclovir Tablets | Each uncoated tablet contains: | ||||
| Acyclovir | IP | 400mg | Anti-viral | |||
| Excipients | ||||||
| 466 | Acyclovir Tablets | Each uncoated tablet contains: | ||||
| Acyclovir | IP | 800mg | Anti-viral | |||
| Excipients | ||||||
| 467 | Thicolchicoside Tablet | Each filmcoated tablet contains: | ||||
| Thicolchicoside | IP | 4mg | anti-inflammatory and analgesic | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 468 | Fluconazole Tablet IP | Each uncoated tablet contains: | ||||
| Fluconazole | IP | 150mg | Anti-fungal | |||
| Excipients | ||||||
| 469 | Citirizine tablets IP | Each filmcoated tablet contains: | ||||
| Citirizine Dihydrochloride | IP | 10mg | Anti-allgeric | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 470 | Atorvastatin & Amlodipine tablet | Each filmcoated tablet contains: | ||||
| Atorvastatin calcium | IP | statins | ||||
| Eq. to.Atorvastatin | 10mg | |||||
| Amlodipine Besylate | IP | |||||
| Eq. to. Amlodipine | 5mg | |||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 471 | Atorvastatin & Amlodipine tablet | Each filmcoated tablet contains: | ||||
| Atorvastatin calcium | IP | statins | ||||
| Eq. to.Atorvastatin | 20mg | |||||
| Amlodipine Besylate | IP | |||||
| Eq. to. Amlodipine | 5mg | |||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 472 | Atorvastatin & Amlodipine tablet | Each filmcoated tablet contains: | ||||
| Atorvastatin calcium | IP | statins | ||||
| Eq. to.Atorvastatin | 40mg | |||||
| Amlodipine Besylate | IP | |||||
| Eq. to. Amlodipine | 10mg | |||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 473 | Minocycline Tablet USP | Each filmcoated tablet contains: | antibiotic | |||
| Minocycline hydrochloride | USP | |||||
| Eq.to.Minocycline | 100mg | |||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 474 | Minocycline Tablet USP | Each filmcoated tablet contains: | ||||
| Minocycline hydrochloride | USP | antibiotic | ||||
| Eq.to.Minocycline | 50mg | |||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 475 | Artemether & Lumefantrine Dispersible Tablets | Each uncoated tablet contains: | ||||
| Artemether | IP | 20mg | Anti-malaria. | |||
| Lumefantrine | USP | 120mg | ||||
| Excipients | ||||||
| 476 | Artemether & Lumefantrine Dispersible Tablets | Each uncoated tablet contains: | ||||
| Artemether | IP | 80mg | Anti-malaria. | |||
| Lumefantrine | USP | 480mg | ||||
| Excipients | ||||||
| 477 | Levetiracetam Tablets | Each uncoated tablet contains: | ||||
| Levetiracetam | IP | 500mg | anticonvulsants | |||
| Excipients | ||||||
| 478 | Levetiracetam Tablets | Each uncoated tablet contains: | ||||
| Levetiracetam | IP | 750mg | anticonvulsants | |||
| Excipients | ||||||
| 479 | Hydroxychloroquine Tablets IP 200mg | Each filmcoated tablet contains: | ||||
| Hydroxychloroquine Sulphate | IP | 200Mmg | antimalarials. | |||
| Colour: Approved colour used | ||||||
| 480 | Hydroxychloroquine Tablets IP 400mg | Each filmcoated tablet contains: | ||||
| Hydroxychloroquine Sulphate | IP | 400mg | antimalarials. | |||
| Colour: Approved colour used | ||||||
| 481 | Ondansetron Orally Disentegratinf Tablets IP | Each orally Disentegrating tablets contain: | ||||
| Ondansetron HCL | IP | |||||
| Eq. to.Ondansetron | 8Mmg | 5-HT3 antagonist | ||||
| Excipients | ||||||
| 482 | Levocetirizine HCL Tablets | Each filmcoated tablet contains: | ||||
| Levocetirizine HCL | IP | 10mg | Anti-allgeric | |||
| Excipients | ||||||
| 483 | Nimesulide & Paracetamol Tablets | Each uncoated tablet contains: | ||||
| Nimesulide | IP | 100mg | Anti-pyretic /analgesic | |||
| Paracetamol | IP | 325mg | ||||
| 484 | Ivermectin Tablets IP | Each uncoated tablet contains: | ||||
| Ivermectin | IP | 12mg | anthelmintics | |||
| Excipients | q.s | |||||
| 485 | Enalapril Meleate Tablet IP | Each uncoated tablet contains: | ||||
| Enalapril Meleate | IP | 2.5mg | angiotensin-converting enzyme (ACE) inhibitors. | |||
| Excipients | ||||||
| 486 | Enalapril Meleate Tablet IP | Each uncoated tablet contains: | ||||
| Enalapril Meleate | IP | 5mg | angiotensin-converting enzyme (ACE) inhibitors. | |||
| Excipients | ||||||
| 487 | Atorvastatin & Ezetemibe tablet | Each filmcoated tablet contains: | ||||
| Atorvastatin calcium | IP | |||||
| Eq. to. Atorvastatin | 10mg | statins | ||||
| Ezetemibe | 10mg | |||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 488 | Indapamide Tablets IP | Each filmcoated tablet contains: | ||||
| Indapamide | IP | 2.5mg | diuretics | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 489 | Terazocin HCL Tablet | Each uncoated tablet contains: | ||||
| Terazocin HCL | IP | |||||
| Eq. to Terazocin | 1mg | alpha-blockers | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 490 | Terazocin HCL Tablet | Each uncoated tablet contains: | ||||
| Terazocin HCL | IP | alpha-blockers | ||||
| Eq. to Terazocin | 2mg | |||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 491 | Levofloxacin Tablet IP | Each filmcoated tablet contains: | ||||
| Levofloxacin Hemihydrate | IP | Anti-bacterial | ||||
| Eq. to Levofloxacin | 500mg | |||||
| Excipients | ||||||
| 492 | Pioglitazone HCL Tablet IP | Each uncoated tablet contains: | anti-diabetic | |||
| Pioglitazone HCL | IP | |||||
| Eq. to Pioglitazone | 15mg | |||||
| Excipients | ||||||
| 493 | Pioglitazone HCL Tablet IP | Each uncoated tablet contains: | ||||
| Pioglitazone HCL | IP | anti-diabetic | ||||
| Eq. to Pioglitazone | 30mg | |||||
| Excipients | ||||||
| 494 | Fexofenadine HCL Tablet IP | Each uncoated tablet contains: | ||||
| Fexofenadine HCL | IP | 120mg | antihistamines | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 495 | Fexofenadine HCL Tablet IP | Each uncoated tablet contains: | ||||
| Fexofenadine HCL | IP | 180mg | antihistamines | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 496 | Ivermectin Tablets | Each filmcoated tablet contains: | anthelmintics | |||
| Ivermectin | IP | 6mg | ||||
| Excipients | ||||||
| 497 | Hydroxychloroquine Sulphate Tablet IP | Each filmcoated tablet contains: | ||||
| Hydroxychloroquine Sulphate | IP | 200mg | antimalarials. | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 498 | Clarithromycin Tablet IP | Each filmcoated tablet contains: | ||||
| Clarithromycin | IP | 250mg | Antibiotic | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 499 | Montelukast Tablet IP | Each filmcoated tablet contains: | ||||
| Montelukast Sodium | IP | |||||
| Eq. to Montelukast | 5mg | leukotriene receptor antagonists (LTRAs) | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 500 | Montelukast Tablet IP | Each filmcoated tablet contains: | ||||
| Montelukast Sodium | IP | |||||
| Eq. to Montelukast | 10mg | leukotriene receptor antagonists (LTRAs) | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 501 | Levocetirizine Tablets IP | Each uncoated tablet contains: | ||||
| Levocetirizine Dihydrochloride | IP | 5mg | ||||
| Excipients | Anti-allgeric | |||||
| 502 | Prasugrel Tablet | Each filmcoated tablet contains: | ||||
| Prasugrel hydrochloride | ||||||
| Eq to Prasugrel | 5mg | anti-platelet | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 503 | Prasugrel Tablet | Each filmcoated tablet contains: | ||||
| Prasugrel hydrochloride | ||||||
| Eq to Prasugrel | 10mg | anti-platelet | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 504 | Entecavir Tablet | Each filmcoated tablet contains: | ||||
| Entecavir | 0.5mg | antiviral | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 506 | Entecavir Tablet | Each filmcoated tablet contains: | ||||
| Entecavir | 10mg | antiviral | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 507 | Lamivudine Tablet IP | Each filmcoated tablet contains: | ||||
| Lamivudine | IP | 150mg | nucleoside reverse transcriptase inhibitors (NRTIs) | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 508 | Nevirapine Tablet IP | Each uncoated tablet contains: | ||||
| Nevirapine | IP | 200mg | (NNRTIs) | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 509 | Efavirenz Tablet IP | Each uncoated tablet contains: | ||||
| Efavirenz | IP | 600mg | non-nucleoside reverse transcriptase inhibitors (NNRTIs). | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 510 | Zidovudine Tablet IP | Each filmcoated tablet contains: | ||||
| Zidovudine | IP | 300mg | nucleoside reverse transcriptase inhibitors-NRTIs | |||
| Excipients | ||||||
| 511 | Abacavir Tablet IP | Each filmcoated tablet contains: | ||||
| Abacavir | IP | 300mg | nucleoside reverse transcriptase inhibitors (NRTIs). | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 512 | Ropinirole Tablet IP | Each filmcoated tablet contains: | ||||
| Ropinirole Hydrochloride | IP | |||||
| Eq. to Ropinirole | 0.25mg | Parkinson's disease and Restless Legs Syndrome.04-Aug-2017 | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 513 | Ropinirole Tablet IP | Each filmcoated tablet contains: | ||||
| Ropinirole Hydrochloride | IP | Parkinson's disease and Restless Legs Syndrome.04-Aug-2017 | ||||
| Eq. to Ropinirole | 0.5mg | |||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 514 | Tenofovir disoproxil Fumarate & Emtricitabine Tablet IP | Tenofovir disoproxil Fumarate | IP | 300mg | control HIV infection | |
| Emtricitabine | IP | 200mg | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 515 | Stavudine , Lamivudine and Nevirapine Tablet IP | Each uncoated tablet contains: | ||||
| Stavudine | IP | 30mg | nucleoside reverse transcriptase inhibitors-NRTIs | |||
| Lamivudine | IP | 150mg | ||||
| Nevirapine | IP | 200mg | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 516 | Zidovudine, lamivudine and nevirapine Tablet IP | Each filmcoated tablet contains: | ||||
| Zidovudine | IP | 300mg | nucleoside reverse transcriptase inhibitors-NRTIs | |||
| Lamivudine | IP | 150mg | ||||
| Nevirapine | IP | 200mg | ||||
| Colour: Approved colour used | ||||||
| 517 | Lopinavir and Ritonavir Tablet IP | Each filmcoated tablet contains: | ||||
| Lopinavir | IP | 200mg | control HIV infection | |||
| Ritonavir | IP | 50mg | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 518 | Lamivudine and Tenofovir disoproxil fumarate Tablet IP | Each filmcoated tablet contains: | ||||
| Lamivudine | IP | 300mg | nucleoside reverse transcriptase inhibitors-NRTIs | |||
| Tenofovir disoproxil fumarate | IP | 300mg | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 519 | Divalproex Sodium Tablet IP | Each filmcoated tablet contains: | ||||
| Divalproex Sodium | IP | 250mg | anti-epileptics. | |||
| Eq. to Valporic Acid | ||||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 520 | Divalproex Sodium Tablet IP | Each filmcoated tablet contains: | ||||
| Divalproex Sodium | IP | 500mg | anti-epileptics. | |||
| Eq. to Valporic Acid | ||||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 521 | Trioxsalen Tablet USP | Each filmcoated tablet contains: | ||||
| Trioxsalen | IP | 5mg | to treat vitiligo | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 522 | Trioxsalen Tablet USP | Each filmcoated tablet contains: | ||||
| Trioxsalen | IP | 25mg | to treat vitiligo | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 523 | Sevelamer HCL Tablet | Each filmcoated tablet contains: | ||||
| Sevelamer HCL | 400mg | hyperphosphatemia | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 524 | Ivabradine HCL Tablet | Each filmcoated tablet contains: | ||||
| Ivabradine HCL | 5mg | hyperpolarization-activated cyclic nucleotide-gated (HCN) channel blockers | ||||
| Eq. to Ivabradine | ||||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 525 | Montelukast Sodium and Levocetirizine Dihydrochloride Dispersible Tablet | Each filmcoated tablet contains: | Anti- allgeric | |||
| Montelukast Sodium | IP | |||||
| EQ. to Montelukast | 5mg | |||||
| Levocetirizine Dihydrochloride | IP | 2.5mg | ||||
| Excipients | ||||||
| 526 | Rasagiline Tablet | Each filmcoated tablet contains: | ||||
| Rasagiline Mesylate | 0.5mg | Parkinson's disease | ||||
| Eq .to Rasagiline | ||||||
| Excipients | ||||||
| 527 | Doxophylline (sustained Release) and Montelukast Tablet | Each uncoated tablet contains: | ||||
| Doxophylline(sustained Release) | IP | 400mg | ||||
| Montelukast sodium | IP | 10mg | Anti-allergies | |||
| Eq to Montelukast | ||||||
| Excipients | ||||||
| 528 | Hyoscine Butylbromide Tablets IP | Each filmcoated tablet contains: | ||||
| Hyoscine Butylbromide | IP | 10mg | anticholinergic drug | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 529 | Tolperisone HCL Tablet | Each uncoated tablet contains: | ||||
| Tolperisone HCL | 100mg | neurological diseases | ||||
| Excipients | ||||||
| 530 | Clonidine Tablet IP | Each uncoated tablet contains: | ||||
| Clonidine | IP | 100mcg | antihypertensive | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 531 | Mycophenol mofetil Tablet USP | Each filmcoated tablet contains: | ||||
| Mycophenol mofetil | 250mg | immunosuppressants. | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 532 | Mycophenol mofetil Tablet USP | Each filmcoated tablet contains: | ||||
| Mycophenol mofetil | 500mg | immunosuppressants. | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 533 | Risperidone Tablet IP | Each filmcoated tablet contains: | ||||
| Risperidone | IP | 3mg | Atypical antipsychotic | |||
| Excipients | ||||||
| 534 | Risperidone Tablet IP | Each filmcoated tablet contains: | ||||
| Risperidone | IP | 4mg | Atypical antipsychotic | |||
| Excipients | ||||||
| 535 | Procycline HCL Tablet IP | Each uncoated tablet contains: | ||||
| Procycline HCL | IP | 2.5mg | Atypical antipsychotic | |||
| Excipients | ||||||
| 536 | Procycline HCL Tablet IP | |||||
| Each uncoated tablet contains: | Atypical antipsychotic | |||||
| Procycline HCL | IP | 5mg | ||||
| Excipients | ||||||
| 537 | Ethambutol Tablet IP | Each filmcoated tablet contains: | ||||
| Ethambutol | IP | 200mg | antibiotic | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 538 | Etoricoxib Tablet IP | Each filmcoated tablet contains: | ||||
| Etoricoxib | IP | 120mg | anti-inflammatory | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 539 | Prazosin HCL Tablet | Each filmcoated sustain release tablet contains: | ||||
| Prazosin HCL | IP | alpha-blockers | ||||
| Eq .to Prazosin HCL | 5mg | |||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 540 | Diltiazem HCL Tablet | Each filmcoated tablet contains: | ||||
| Diltiazem HCL | IP | 60mg | calcium-channel blockers | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 541 | Diltiazem HCL Tablet | Each filmcoated tablet contains: | ||||
| Diltiazem HCL | IP | 30 mg | calcium-channel blockers | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 542 | Nebivilol HCL Tablet IP | Each uncoated tablet contains: | ||||
| Nebivilol HCL | IP | |||||
| Eq to Nebivilol | 5mg | beta blockers | ||||
| Excipients | ||||||
| 543 | Ciprofloxacin and Tinidazole Tablet | Each uncoated tablet contains: | ||||
| Ciprofloxacin | IP | 500mg | antibiotics | |||
| Tinidazole | IP | 600mg | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 544 | Ezetimibe Tablet IP | Each uncoated tablet contains: | ||||
| Ezetimibe | IP | 10mg | cholesterol-lowering medications | |||
| Excipients | ||||||
| 545 | Deflazacort Tablet | Each uncoated tablet contains: | ||||
| Deflazacort | IP | 18mg | corticosteroids | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 546 | Torsemide Tablet IP | Each uncoated tablet contains: | ||||
| Torsemide | IP | 20mg | diuretics | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 547 | Valsartan Tablet IP | Each filmcoated tablet contains: | ||||
| Valsartan | IP | 40mg | angiotensin receptor blockers | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 548 | Valsartan Tablet IP | Each filmcoated tablet contains: | ||||
| Valsartan | IP | 80mg | angiotensin receptor blockers | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 549 | Nicoumalone Tablet IP | Each uncoated tablet contains: | ||||
| Nicoumalone | IP | 2mg | anticoagulants. | |||
| Excipients | ||||||
| 550 | Nicoumalone Tablet IP | Each uncoated tablet contains: | ||||
| Nicoumalone | IP | 4mg | anticoagulants. | |||
| Excipients | ||||||
| 551 | Olanzapine Tablet IP | Each filmcoated tablet contains: | ||||
| Olanzapine | IP | 10mg | atypical antipsychotics. | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 552 | Trihexyphenidyl hydrochloride Tablet IP | Each uncoated tablet contains: | ||||
| Trihexyphenidyl hydrochloride | IP | 2mg | anticholinergics | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 553 | Nortriptyline Hydrochloride Tablet IP | Each uncoated tablet contains: | ||||
| Nortriptyline Hydrochloride | IP | |||||
| Eq. to Nortriptyline | 25mg | tricyclic antidepressants | ||||
| Excipients | ||||||
| 554 | Colour: Approved colour used | |||||
| Frusemide and Spironolactone Tablet | Each filmcoated tablet contains: | |||||
| Frusemide | IP | 20mg | aldosterone receptor antagonists | |||
| Spironolactone | IP | 50mg | ||||
| Excipients | ||||||
| 555 | Colour: Approved colour used | |||||
| Propranolol Tablet IP | Each Uncoated tablet contains: | |||||
| Propranolol HCL | IP | 40mg | beta blockers | |||
| 556 | Excipients | |||||
| Repaglinide Tablet IP | Each Uncoated tablet contains: | |||||
| Repaglinide | IP | 0.5mg | antidiabetic | |||
| Excipients | ||||||
| 557 | Repaglinide Tablet IP | Each Uncoated tablet contains: | ||||
| Repaglinide | IP | 1mg | antidiabetic | |||
| Excipients | ||||||
| 558 | Repaglinide Tablet IP | Each Uncoated tablet contains: | ||||
| Repaglinide | IP | 2mg | antidiabetic | |||
| Excipients | ||||||
| 559 | Hydrochlorothiazide Tablet IP | Each Uncoated tablet contains: | ||||
| Hydrochlorothiazide | IP | 12.5mg | diuretics/"water pills | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 560 | Fenofibrate Tablet | Each filmcoated tablet contains: | ||||
| Fenofibrate | IP | 160mg | Fibric Acid Agents | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 561 | Donepezil hydrochloride Tablet IP | Each filmcoated tablet contains: | ||||
| Donepezil hydrochloride | IP | 10mg | Acetylcholinesterase inhibitor | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 562 | Donepezil hydrochloride Tablet IP | Each filmcoated tablet contains: | ||||
| Donepezil hydrochloride | IP | 5mg | Acetylcholinesterase inhibitor | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 563 | Solifenacin Tablet IP | Each filmcoated tablet contains: | ||||
| Solifenacin succinate | IP | 5mg | antimuscarinics. | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 564 | Solifenacin Tablet IP | Each filmcoated tablet contains: | ||||
| Solifenacin succinate | IP | 10mg | antimuscarinics. | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 565 | Bisoprolol Fumarate Tablet USP | Each filmcoated tablet contains: | ||||
| Bisoprolol Fumarate | USP | 5mg | antihypertensive agents. | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 566 | Quetiapine Tablet IP | Each filmcoated tablet contains: | ||||
| Quetiapine Fumarate | IP | |||||
| Eq. to quetiapine | 25mg | anti-psychotic drug (atypical type). | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 567 | Quetiapine Tablet IP | Each filmcoated tablet contains: | ||||
| Quetiapine Fumarate | IP | |||||
| Eq. to quetiapine | 50mg | anti-psychotic drug (atypical type). | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 568 | Amisulpride Tablet IP | Each filmcoated tablet contains: | ||||
| Amisulpride | IP | 50mg | antipsychotics | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 569 | Amisulpride Tablet IP | Each filmcoated tablet contains: | ||||
| Amisulpride | IP | 100mg | antipsychotics | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 570 | Baclofen Tablet IP | Each Uncoated tablet contains: | ||||
| Baclofen | IP | 10mg | skeletal muscle relaxants | |||
| Excipients | ||||||
| 571 | Baclofen Tablet IP | Each Uncoated tablet contains: | ||||
| Baclofen | IP | 20mg | skeletal muscle relaxants | |||
| Excipients | ||||||
| 572 | Voglibose Tablet IP | Each Uncoated tablet contains: | ||||
| Voglibose | IP | 0.3mg | Alpha glucosidase inhibitors | |||
| Excipients | ||||||
| 573 | Methylcobalamin Tablet | Each Uncoated tablet contains: | ||||
| Methylcobalamin | IP | 1500mcg | Alpha glucosidase inhibitors | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 574 | Aciclovir Tablet IP | Each Uncoated tablet contains: | ||||
| Aciclovir | IP | 800mg | Anti-viral | |||
| Excipients | ||||||
| 575 | Azathioprine Tablets IP | Each Uncoated tablet contains: | ||||
| Azathioprine | IP | 50mg | immunosuppressants | |||
| Excipients | ||||||
| 576 | Acetazolamide Tablet IP | Each Uncoated tablet contains: | ||||
| Acetazolamide | IP | 250 mg | carbonic anhydrase inhibitors | |||
| Excipients | ||||||
| 577 | Leflunomide Tablet IP | Each filmcoated tablet contains: | ||||
| Leflunomide | IP | 10mg | rheumatoid arthritis | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 578 | Leflunomide Tablet IP | Each filmcoated tablet contains: | ||||
| Leflunomide | IP | 20mg | rheumatoid arthritis | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 579 | Gliclazide Tablet IP | Each Uncoated tablet contains: | ||||
| Gliclazide | IP | 40mg | antidiabetic | |||
| Excipients | ||||||
| 580 | Gliclazide Tablet IP | Each Uncoated tablet contains: | ||||
| Gliclazide | IP | 5mg | antidiabetic | |||
| Excipients | ||||||
| 581 | Digoxin Tablet IP | Each Uncoated tablet contains: | ||||
| Digoxin | IP | 0.25mg | cardiac glycosides | |||
| Excipients | ||||||
| 582 | Mebeverine Hydrochloride Tablet IP | Each filmcoated tablet contains: | ||||
| Mebeverine Hydrochloride | IP | 135mg | antispasmodic | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 583 | Alfuzosin Hydrochloride Tablet | Each filmcoated extended release tablet contain: | alpha blockers | |||
| Alfuzosin Hydrochloride | IP | 10mg | ||||
| Excipients | ||||||
| 584 | Oxcarbazepine Tablet IP | Each Uncoated tablet contains: | ||||
| Oxcarbazepine | IP | 150mg | anticonvulsants | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 585 | Oxcarbazepine Tablet IP | Each Uncoated tablet contains: | ||||
| Oxcarbazepine | IP | 300mg | anticonvulsants | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 586 | Oxcarbazepine Tablet IP | Each Uncoated tablet contains: | ||||
| Oxcarbazepine | IP | 600mg | anticonvulsants | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 587 | Clonazepam Tablet IP | Each Uncoated tablet contains: | ||||
| Clonazepam | IP | 0.25mg | panic disorder (with or without agoraphobia) | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 588 | Prazosin Hydrochloride Tablet IP | Each filmcoated tablet contains: | ||||
| Prazosin Hydrochloride | IP | |||||
| Eq. to Prazosin | 1mg | alpha blockers | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 589 | Prazosin Hydrochloride Tablet IP | Each filmcoated tablet contains: | ||||
| Prazosin Hydrochloride | IP | |||||
| Eq. to Prazosin | 2mg | alpha blockers | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 590 | Aceclofenac Tablet IP | Each Uncoated tablet contains: | ||||
| Aceclofenac | IP | 100mg | pain, swelling, inflammation and fever. | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 591 | Aceclofenac Tablet IP | Each Uncoated tablet contains: | ||||
| Aceclofenac | IP | 200mg | pain, swelling, inflammation and fever. | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 592 | Amitriptyline Hydrochloride Tablet IP | Each filmcoated tablet contains: | ||||
| Amitriptyline Hydrochloride | IP | 10mg | tricyclic antidepressants. | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 593 | Theophylline Prolonged release Tablets IP | Each uncoated prolonged release tablet contains: | ||||
| Theophylline Anhydrous | IP | 400mg | xanthines. | |||
| Excipients | ||||||
| 594 | Allopurinol Tablet IP | Each Uncoated tablet contains: | ||||
| Allopurinol | IP | 100mg | xanthine oxidase inhibitors | |||
| Excipients | ||||||
| 595 | Doxophylline Tablet IP | Each Uncoated tablet contains: | ||||
| Doxophylline | IP | 400mg | asthma. | |||
| 596 | Chlordiazepoxide Tablet IP | Each filmcoated tablet contains: | ||||
| Chlordiazepoxide | IP | 25mg | benzodiazepines. | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 597 | Piracetam Tablet | Each filmcoated tablet contains: | ||||
| Piracetam | IP | 800mg | synthetic nootropic | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 598 | Sumatripta Succinate Tablet | Each filmcoated tablet contains: | ||||
| Sumatripta Succinate | IP | |||||
| Eq. to Sumatripan | 25mg | serotonin receptor agonists | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 599 | Hydroxyzine Hydrochloride Tablet IP | Each filmcoated tablet contains: | ||||
| Hydroxyzine Hydrochloride | IP | 10mg | antihistamines | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 600 | Cinnarlzine Tablet IP | Each Uncoated tablet contains: | ||||
| Cinnarlzine | IP | 25mg | antihistamines | |||
| Excipients | ||||||
| 601 | Azathioprine Tablets IP | Each Uncoated tablet contains: | ||||
| Azathioprine | IP | 25mg | immunosuppressants | |||
| Excipients | ||||||
| 602 | Topiramine Tablet IP | Each filmcoated tablet contains: | ||||
| Topiramine | IP | 25mg | anticonvulsants. | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 603 | Lamotrigine Dispersible Tablet IP | Each filmcoated tablet contains: | ||||
| Lamotrigine | IP | 50mg | anticonvulsants. | |||
| Excipients | ||||||
| 604 | Lamotrigine Dispersible Tablet IP | Each filmcoated tablet contains: | ||||
| Lamotrigine | IP | 50mg | anticonvulsants. | |||
| Excipients | ||||||
| 605 | Lamotrigine Dispersible Tablet IP | Each filmcoated tablet contains: | ||||
| Lamotrigine | IP | 100mg | anticonvulsants. | |||
| Excipients | ||||||
| 606 | Methyldopa Tablet IP | Each filmcoated tablet contains: | ||||
| Methyldopa | IP | |||||
| Eq. to anhydrous Manodopa | 125mg | centrally acting antiadrenergics. | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 607 | Methyldopa Tablet IP | Each filmcoated tablet contains: | ||||
| Methyldopa | IP | |||||
| Eq. to anhydrous Manodopa | 250mg | centrally acting antiadrenergics. | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 608 | Esomeprazol Tablet IP | Each enteric coated tablet contain: | ||||
| Esomeprazol Magnesium Trihydrates | IP | |||||
| Eq. to Esomeprazol | 20mg | proton pump inhibitors | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 609 | Zolpidem Tartrate tablet IP | Each filmcoated tablet contains: | ||||
| Zolpidem Tartrate | IP | 10mg | sedative-hypnotics. | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 610 | Levetiracetam Tablets USP | Each filmcoated tablet contains: | ||||
| Levetiracetam | USP | 1000mcg | anticonvulsants. | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 612 | Ropinirole Tablet IP | Each filmcoated tablet contains: | ||||
| Ropinirole | IP | 1mg | dopamine agonists. | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 613 | Ropinirole Tablet IP | Each filmcoated tablet contains: | ||||
| Ropinirole | IP | 2mg | dopamine agonists. | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 614 | Warfarin Tablet IP | Each filmcoated tablet contains: | ||||
| Warfarin Sodium | IP | 5mg | anticoagulants | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 615 | Risperidone Tablet IP | Each uncoated tablet contains: | ||||
| Risperidone | IP | 1mg | Atypical antipsychotic | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 616 | Risperidone Tablet IP | Each uncoated tablet contains: | ||||
| Risperidone | IP | 2mg | Atypical antipsychotic | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 617 | Metoprolol tartrate tablet IP | Each uncoated tablet contains: | ||||
| Metoprolol tartrate | IP | 25mg | beta blockers. | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 618 | Metoprolol tartrate tablet IP | Each uncoated tablet contains: | ||||
| Metoprolol tartrate | IP | 50mg | beta blockers. | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 619 | Rizatriptan Tablet IP | Each uncoated tablet contains: | ||||
| Rizatriptan Benzoate | IP | |||||
| Eq. to rizatriptan | 5mg | selective serotonin receptor agonists. | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 620 | Rizatriptan Tablet IP | Each uncoated tablet contains: | ||||
| Rizatriptan Benzoate | IP | |||||
| Eq. to rizatriptan | 10mg | selective serotonin receptor agonists. | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 621 | Mirtazapine Tablet USP | Each filmcoated tablet contains: | ||||
| Mirtazapine(Anhydrous) | USP | 7.5mg | antidepressants | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 622 | Mirtazapine Tablet USP | Each filmcoated tablet contains: | ||||
| Mirtazapine(Anhydrous) | USP | 15mg | antidepressants | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 623 | Drotaverine HCL tablet IP | Each uncoated tablet contains: | ||||
| Drotaverine HCL | 40mg | Anti-inflammtory | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 624 | Drotaverine HCL tablet IP | Each uncoated tablet contains: | ||||
| Drotaverine HCL | 80mg | Anti-inflammtory | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 625 | Topiramate Tablet IP | Each filmcoated tablet contains: | ||||
| Topiramate | IP | 50Mmg | anticonvulsants or antiepileptic drugs | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 626 | Irbesartan tablet | Each uncoated tablet contains: | ||||
| Irbesartan | IP | 150mg | angiotensin receptor blockers | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 627 | Irbesartan tablet | Each uncoated tablet contains: | ||||
| Irbesartan | IP | 300mg | angiotensin receptor blockers | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 628 | Glucosamine tablet USP | Each filmcoated tablet contains: | ||||
| Glucosamine Sulphate potassium chloride | USP | 500mg | Hexosamines | |||
| Eq. to glucosamine | 296mg | |||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 629 | Pyridostigmine Tablet BP | Each filmcoated tablet contains: | ||||
| Pyridostigmine | BP | 60mg | acetylcholinesterase | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 630 | Carbergoline Tablet IP | Each uncoated tablet contains: | ||||
| Carbergoline | IP | 0.25mg | dopamine receptor agonists | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 631 | Carbergoline Tablet IP | Each uncoated tablet contains: | ||||
| Carbergoline | IP | 0.5mg | dopamine receptor agonists | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 632 | Methotrexate Tablet IP | Each filmcoated tablet contains: | ||||
| Methotrexate | IP | 2.5mg | antimetabolites | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 633 | Misoprostol Tablet IP | Each filmcoated tablet contains: | ||||
| Misoprostol | IP | 200mcg | a synthetic prostaglandin E1 (PGE1). | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 634 | Aripiprazole Tablet IP | Each uncoated tablet contains: | ||||
| Aripiprazole | IP | 20mg | antipsychotics | |||
| Excipients | ||||||
| 635 | Sertraline HCL tablet IP | Each uncoated tablet contains: | ||||
| Sertraline HCL | IP | |||||
| Eq. to Sertraline | 100mg | antidepressant | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 636 | Flavoxate Tablet | Each uncoated tablet contains: | ||||
| Flavoxate HCL | IP | 200mg | antimuscarinics | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 637 | Mirtazapine Tablet USP | Each uncoated tablet contains: | ||||
| Mirtazapine | USP | 30mg | antidepressants | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 638 | Deflazacort Tablet | Each uncoated tablet contains: | ||||
| Deflazacort | 24mg | corticosteroids. | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 639 | Mefloquine Tablet IP | Each uncoated tablet contains: | ||||
| Mefloquine hcl | IP | |||||
| Eq. to mefloquine Base | 250mg | antimalarials. | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 640 | Carbamazepine Tablet IP | Each uncoated tablet contains: | ||||
| Carbamazepine | IP | 200mg | anticonvulsant or anti-epileptic drug. | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 641 | Nitrofurantoin Tablet IP | Each uncoated tablet contains: | ||||
| Nitrofurantoin | IP | 100mg | antibiotics. | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 642 | Isosorbide mononitrate Tablet IP | Each uncoated tablet contains: | ||||
| Diluted Isosorbide mononitrate | IP | |||||
| Eq. to isosorbide mononitrate | 10mg | Nitrate | ||||
| Excipients | ||||||
| 643 | Paroxetine HCL tablet IP | Each uncoated tablet contains: | ||||
| Paroxetine HCL | IP | |||||
| Eq. to Paroxetine | 20mg | Anti-deperssent | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 644 | Paroxetine HCL tablet IP | Each uncoated tablet contains: | ||||
| Paroxetine HCL | IP | |||||
| Eq. to Paroxetine | 30mg | Anti-deperssent | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 645 | Citalopram Tablet IP | Each uncoated tablet contains: | ||||
| Citalopram Hydrobromide | IP | |||||
| Eq. to Citalopram | 10mg | Antidepressant | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 646 | Citalopram Tablet IP | Each uncoated tablet contains: | ||||
| Citalopram Hydrobromide | IP | |||||
| Eq. to Citalopram | 20mg | Antidepressant | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 647 | Torsemide Tablet IP | Each uncoated tablet contains: | ||||
| Torsemide | IP | 5mg | diuretics | |||
| Excipients | ||||||
| 648 | Montelukast Sodium and Fexofenadine Tablet | Each filmcoated tablet contains: | ||||
| Montelukast Sodium | IP | |||||
| Eq to Montelukast | 10mg | |||||
| Fexofenadine hcl | IP | 120mg | leukotriene receptor antagonists | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 649 | Divalproex Sodium Extended release Tablet IP | Each filmcoated tablet contains: | ||||
| Divalproex Sodium | IP | |||||
| Eq. to Valporic Acid | 250mg | Anticonvulsants | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 650 | Divalproex Sodium Extended release Tablet IP | Each filmcoated tablet contains: | ||||
| Divalproex Sodium | IP | |||||
| Eq. to Valporic Acid | 500mg | Anticonvulsants | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 651 | Amisulpride Tablet IP | Each filmcoated tablet contains: | ||||
| Amisulpride | IP | 50mg | schizophrenia. | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 652 | Amisulpride Tablet IP | Each filmcoated tablet contains: | ||||
| Amisulpride | IP | 100mg | schizophrenia. | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 653 | Amisulpride Tablet IP | Each filmcoated tablet contains: | ||||
| Amisulpride | IP | 200mg | schizophrenia. | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 654 | Aripiprazole Tablet IP | Each filmcoated tablet contains: | ||||
| Aripiprazole | IP | 10mg | antipsychotics. | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 655 | Aripiprazole Tablet IP | Each filmcoated tablet contains: | ||||
| Aripiprazole | IP | 20mg | antipsychotics. | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 656 | Aripiprazole Tablet IP | Each filmcoated tablet contains: | ||||
| Aripiprazole | IP | 15mg | antipsychotics. | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 657 | Aripiprazole Tablet IP | Each filmcoated tablet contains: | ||||
| Aripiprazole | IP | 30mg | antipsychotics. | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 658 | Quetiapine Tablet IP | Each filmcoated tablet contains: | ||||
| Quetiapine fumarate | IP | |||||
| Eq. to Quetiapine | 100mg | schizophrenia | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 659 | Quetiapine Tablet IP | Each filmcoated tablet contains: | ||||
| Quetiapine fumarate | IP | |||||
| Eq. to Quetiapine | 200mg | schizophrenia | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 660 | Quetiapine Tablet IP | Each filmcoated tablet contains: | ||||
| Quetiapine fumarate | IP | |||||
| Eq. to Quetiapine | 50mg | schizophrenia | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 661 | Mirtazapine Tablet | Each filmcoated tablet contains: | ||||
| Mirtazapine | IP | 7.5mg | antidepressants. | |||
| Excipients | ||||||
| 662 | Mirtazapine Tablet | Each filmcoated tablet contains: | ||||
| Mirtazapine | IP | 15mg | antidepressants. | |||
| Excipients | ||||||
| 663 | Sertraline HCL Tablet IP | Each filmcoated tablet contains: | ||||
| Sertraline HCL | IP | |||||
| Eq. to Sertraline | 25mg | antidepressants | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 664 | Sertraline HCL Tablet IP | Each filmcoated tablet contains: | ||||
| Sertraline HCL | IP | |||||
| Eq. to Sertraline | 50mg | antidepressants | ||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 665 | Fluvoxamine Tablet IP | Each filmcoated tablet contains: | ||||
| Fluvoxamine maleate | IP | 50mg | Antidepressant | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 666 | Fluvoxamine Tablet IP | Each filmcoated tablet contains: | ||||
| Fluvoxamine maleate | IP | 100 mg | Antidepressant | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 667 | Amitriptyline Hydrochloride Tablet IP | Each filmcoated tablet contains: | ||||
| Amitriptyline Hydrochloride | IP | 25mg | antidepressants. | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 667 | Lamotrigine Dispersible Tablet IP | Each uncoated dispersible tablet contains: | anticonvulsants. | |||
| Lamotrigine | IP | 50mg | ||||
| Excipients | ||||||
| 668 | Lamotrigine Dispersible Tablet IP | Each uncoated dispersible tablet contains: | ||||
| Lamotrigine | IP | 100mg | anticonvulsants. | |||
| Excipients | ||||||
| 669 | Donepezil Hydrochloride Tablet IP | Each filmcoated tablet contains: | ||||
| Donepezil Hydrochloride | IP | 5mg | Acetylcholinesterase inhibitor | |||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 670 | Montelukast Sodium 10mg & Bambuterol Hydrochloride 10 mg tablet | Each uncoated tablet contains: | ||||
| Montelukast Sodium Equivalent to | IP | |||||
| Montelukast ---------- | 10mg | Anti-allgeric | ||||
| Bambuterol Hydrochloride …………. | IP | 10mg | ||||
| colour: Ferric Oxide (yellow) | USP-NF | |||||
| 671 | Minocycline Hydrochloride tablet USP | Composition | ||||
| Each filmcoated tablet contains: | ||||||
| Minocycline Hydrochloride | USP | Anti-bacterial | ||||
| Eq. to minocycline | 50mg | |||||
| Excipients | ||||||
| Colors: Quinolone yellow lake, sunset yellow FCF & Titanium dioxide | IP | |||||
| 672 | Minocycline Hydrochloride tablet USP | Composition | ||||
| Each filmcoated tablet contains: | ||||||
| Minocycline Hydrochloride | USP | |||||
| Eq. to minocycline | 100mg | Anti-bacterial | ||||
| Excipients | ||||||
| Colors: Quinolone yellow lake, sunset yellow FCF & Titanium dioxide | ||||||
| 673 | Zolpidem tablet IP | Composition | ||||
| Each filmcoated tablet contains: | ||||||
| Zolpidem Tartrate | IP | 5mg | sedative-hypnotics. | |||
| colors: Titanium dioxide & terric oxide (red) | ||||||
| 674 | Zolpidem tablet IP | Composition | ||||
| Each filmcoated tablet contains: | ||||||
| Zolpidem Tartrate | IP | 10mg | sedative-hypnotics. | |||
| colors: Titanium dioxide & terric oxide (red) | ||||||
| 675 | Solifenacin Succinate Tablets | Composition | ||||
| Each filmcoated tablet contains: | ||||||
| Solifenacin Succinate | USP-NF | 5mg | antimuscarinics | |||
| Color: ferric oxide ( yellow) Titanium dioxide | IP | |||||
| 676 | Solifenacin Succinate Tablets | Composition | ||||
| Each filmcoated tablet contains: | ||||||
| Solifenacin Succinate | USP-NF | 10mg | antimuscarinics | |||
| Color: ferric oxide ( yellow) Titanium dioxide | IP | |||||
| 677 | Alfuzosin Prolonged release tablet IP 10 mg | Composition | ||||
| Each filmcoated tablet contains: | ||||||
| Alfuzosin Hydrochloride | IP | 10mg | alpha blockers. | |||
| colors: Titanium dioxide | IP | |||||
| 678 | Trbinafine 250mg tablet USP | Composition | ||||
| Each filmcoated tablet contains: | ||||||
| Trbinafine Hydrochloride | USP | 250mg | antifungal | |||
| Eq.to trbinafine | ||||||
| 679 | Nimesulide 100mg & Paracetamol 325mg tablets | Composition | ||||
| Each filmcoated tablet contains: | ||||||
| Nimesulide | BP | 100mg | Nimesulide (NSAID) and Paracetamol (Antipyretic) | |||
| Paracetamol | IP | 325mg | ||||
| Excipients | ||||||
| 680 | Piroxicam Tablets 20mg | Each dispersible tablet contains: | ||||
| Piroxicam USP | 20mg | NSAIDs | ||||
| Excipients | ||||||
| 681 | Nimesulide and Paracetamol tablet | Each uncoated tablet contains: | ||||
| Nimesulide | BP | 100mg | ||||
| Paracetamol | IP | 325mg | Nimesulide (NSAID) and Paracetamol (Antipyretic) | |||
| Excipients | ||||||
| 682 | Solifenacin Succinate Tablets | Composition | ||||
| Each filmcoated tablet contains: | USP-NF | 10mg | antimuscarinics | |||
| Solifenacin Succinate | IP | |||||
| Color: ferric oxide ( yellow) | ||||||
| 683 | Alfuzosin Prolonged release tablet IP 10 mg | Composition | ||||
| Each filmcoated tablet contains: | ||||||
| Alfuzosin Hydrochloride | USP | 10mg | alpha blockers | |||
| Colour: Titanium dioxide | IP | |||||
| 684 | Trbinafine 250mg tablet USP | Composition | ||||
| Each filmcoated tablet contains: | ||||||
| Trbinafine Hydrochloride | USP | 250mg | Anti-fungal | |||
| Eq. to Trbinafine | ||||||
| 685 | Nimesulide 100mg &Paracetamol 325mg tablets | Composition | ||||
| Each filmcoated tablet contains: | ||||||
| Nimesulide | 100mg | |||||
| Paracetamol | 325mg | Nimesulide (NSAID) and Paracetamol (Antipyretic) | ||||
| Excipients | ||||||
| 686 | Rantidine Tablet | Each filmcoated tablet contains: | ||||
| Rantidine | IP | 150mg | H2 blockers. | |||
| Excipients | q.s | |||||
| Colour: Ferric oxide (red) | ||||||
| 687 | Acetaminophen and Diclofenac Potassium Tablet | Each filmcoated tablet contains: | ||||
| Acetaminophen | IP | 500mg | ||||
| Diclofenac Potassium | IP | 50mg | anti-inflammatory drug (NSAID). | |||
| Excipients | ||||||
| colour: Sunset yellow | ||||||
| 688 | Ofloxacin with Ornidazole Tablet | Each filmcoated tablet contains: | ||||
| Ofloxacin | IP | 200mg | quinolone antibiotics. | |||
| Ornidazole | IP | 500mg | ||||
| Excipients | ||||||
| colour: Titanium dioxide | ||||||
| 689 | Norfloxacin& Metronidazole Tablets | Each filmcoated tablet contains: | ||||
| Norfloxacin | IP | 500mg | quinolone antibiotics | |||
| Metronidazole | IP | 400mg | ||||
| colour: Ponceau 4R | ||||||
| 690 | Ciprofloxacin tablets | Each filmcoated tablet contains: | ||||
| Ciprofloxacin Hydrochloride | IP | 250mg | Anti-bacterial | |||
| Eq. to Ciprofloxacin | ||||||
| Excipients | ||||||
| colour: Titanium dioxide | ||||||
| 691 | Ciprofloxacin tablets | Each filmcoated tablet contains: | ||||
| Ciprofloxacin Hydrochloride | IP | 500mg | Anti-bacterial | |||
| Eq. to Ciprofloxacin | ||||||
| Excipients | ||||||
| colour: Titanium dioxide | ||||||
| 692 | Ofloxacine Tablet | Each filmcoated tablet contains: | ||||
| Ofloxacine | IP | 400mg | antibiotics | |||
| Excipients | ||||||
| colour: Titanium dioxide | ||||||
| 693 | Diclofenac with Paracetamol Tablet | Each filmcoated tablet contains: | ||||
| Diclofenac sodium | IP | 100mg | ||||
| Paracetamol | IP | 325mg | Anti-inflammtory | |||
| Excipients | ||||||
| colour: Titanium dioxide | ||||||
| 694 | Deflazacort 6 Tablet | Each uncoated tablet contains: | ||||
| Deflazacort | IP | 6mg | corticosteroids. | |||
| Excipients | ||||||
| 695 | Deflazacort 6 Tablet | Each uncoated tablet contains: | ||||
| Deflazacort | IP | 12mg | corticosteroids. | |||
| Excipients | ||||||
| 696 | Terbinafine 250 Tablet | Each uncoated tablet contains: | ||||
| Terbinafine Hydrochloride | USP | 250mg | Anti-fungal | |||
| Excipients | ||||||
| 697 | Terbinafine 250 Tablet | Each uncoated tablet contains: | ||||
| Terbinafine Hydrochloride | USP | 500mg | Anti-fungal | |||
| Excipients | ||||||
| 698 | Levocetirizine and fexofinadine Tablet | Each filmcoated tablet contains: | ||||
| Levocetirizine Hydrochloride | IP | 2.5mg | antihistamines | |||
| fexofinadine Hydrochloride | IP | 120mg | ||||
| colour: Titanium dioxide | ||||||
| 700 | Fluconazole tablet | Each uncoated tablet contains: | ||||
| Fluconazole | IP | 150mg | Anti-fungal | |||
| Excipients | ||||||
| 701 | Cefprozil Tablet | Each filmcoated tablet contains: | ||||
| Cefprozil | IP | 250mg | cephalosporin antibiotics. | |||
| colour: Titanium dioxide | ||||||
| 702 | Cefprozil Tablet | Each filmcoated tablet contains: | ||||
| Cefprozil | IP | 500mg | cephalosporin antibiotics. | |||
| colour: Titanium dioxide | ||||||
| 703 | Diclofenac with Paracetamol Tablet | Each uncoated tablet contains: | ||||
| Diclofenac | IP | 50mg | ||||
| Paracetamol | IP | 325mg | Anti-inflammatory | |||
| Excipients | ||||||
| 704 | Sidenafil Citrate Tablet | Each filmcoated tablet contains: | ||||
| Sidenafil Citrate | IP | 50mg | phosphodiesterase (PDE) inhibitors | |||
| Excipients | ||||||
| colour: Titanium dioxide | ||||||
| 705 | Sidenafil Citrate Tablet | Each filmcoated tablet contains: | ||||
| Sidenafil Citrate | IP | 10mg | phosphodiesterase (PDE) inhibitors | |||
| Excipients | ||||||
| colour: Titanium dioxide | ||||||
| 706 | Riboflavin,folic acid Niacinamide& Lactic acid Bacillus spores Tablet | Each uncoated tablet contains: | ||||
| Riboflavin | IP | 10mg | vitamin | |||
| folic acid | IP | 1.5mg | ||||
| Niacinamide | IP | 100mg | ||||
| Lactic acid Bacillus | IP | 60million spores | ||||
| Excipients | q.s | |||||
| 707 | Zinc sulphate Tablet BP 50mg | Each filmcoated tablet contains: | ||||
| Zinc sulphate Monohydrate 137.232mg | IP | |||||
| Eq. to Elemental Zinc | 50mg | Zinc deficiency | ||||
| Excipients | ||||||
| colour Titanium Dioxide IP | ||||||
| 708 | Cefuroxime Axetil tablet BP 500mg (for export) | Each filmcoated tablet contains: | ||||
| Cefuroxime Axetil | BP | |||||
| Eq. to Cefuroxime | 500mg | cephalosporin antibiotics | ||||
| Excipients | q.s | |||||
| Colour: Approved colour used | ||||||
| 709 | Sildosin 4mg & Dutasteride 0.5mg Tablets | Each Film Coated Tablet Contains: | ||||
| Sildosin | 4mg | |||||
| Dutastreride | IP | 0.5mg | ||||
| Excipients | q.s | |||||
| Colour quinoline Yellows ws | ||||||
| 710 | Sildosin 8mg &Dutasteride 0.5mg Tablets | Each Film Coated Tablet Contains: | ||||
| Sildosin | 8mg | |||||
| Dutastreride | IP | 0.5mg | ||||
| Excipients | q.s | |||||
| Colour:Lake Sunset yellow | ||||||
| 711 | Acebrophylline Sustained release | Each Film Coated Sustained release Tablet Contains: | ||||
| tablet 200mg | Acebrophylline | IP | 200mg | |||
| Excipients | q.s | |||||
| Colour: Approved colour used | ||||||
| 712 | Tapentadol Tablet 50mg | Each Film Coated Tablet Contains: | ||||
| Tapentadol Hydrochloride | IP | 50mg | ||||
| Eq.to Tapentadol | q.s | |||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 714 | Tapentadol Tablet 100mg | Each Film Coated Tablet Contains: | ||||
| Tapentadol Hydrochloride | IP | 100mg | ||||
| Eq.to Tapentadol | q.s | |||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 715 | Tapentadol Tablet 200mg | Each Film Coated Tablet Contains: | ||||
| Tapentadol Hydrochloride | IP | 200mg | ||||
| Eq.to Tapentadol | q.s | |||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 716 | Azithromycin Tablets IP | Each Film Coated Tablet Contains: | ||||
| Azithromycin (As Dihydrate) | IP | 250mg | ||||
| Eq.to Anhydrous | ||||||
| Azithromycin | ||||||
| Excipients | ||||||
| Coloue: Yellow Oxide Of Iron | ||||||
| 717 | Azithromycin Tablets IP | Each Film Coated Tablet Contains: | ||||
| Azithromycin (As Dihydrate) | IP | 500mg | ||||
| Eq.to Anhydrous | ||||||
| Azithromycin | ||||||
| Excipients | ||||||
| Coloue: Yellow Oxide Of Iron | ||||||
| 718 | Paracetamol, Phenylephrine Hydrochloride | Each uncoated Tablet Contains: | ||||
| &Chlopheniramine Maleate Tablets | Paracetamol | IP | 500mg | |||
| Phenylephrine HCl. | IP | 10mg | ||||
| Chlorpheniramine Maleate | IP | 2mg | ||||
| 719 | Amoxycillin Dispersible Tablet IP | Each Uncoated dispersible tablet Contains: | ||||
| Amoxycillin Trihydrate | IP | 250mg | ||||
| Eq.to Amoxycillin | Q.S | |||||
| Excipients | ||||||
| Colour: Approved colour used | ||||||
| 720 | Acecolofenac, Paracetamol,Cetirizine Dihydrochloride, Phenylephrine Hydrochloride & Caffeine Tablets | Each uncoated bilayered tablet contains: | ||||
| Aceclofenac | IP | 100mg | ||||
| Paracetamol | IP | 325mg | ||||
| Phenylephrine HCl. | IP | 5mg | ||||
| Cetirizine Dihydrochloride | IP | 10mg | ||||
| Caffeine Anhydrous | IP | 25mg | ||||
| Excipients | q.s | |||||
| 721 | Sildenafil Citrate tablets IP 100mg | Each Film coated tablet Contains: | ||||
| Sildenafil Citrate | IP | 100mg | ||||
| Eq.to Sildenafil | q.s | |||||
| Excipients | ||||||
| Coloue: Red oxide of oron,Lake of Indigo | ||||||
| 722 | Diclofenac Potassium, Paracetamol &Serratiopeptidase Tablets | Each Film Coated tablet Contains: | ||||
| Diclofenac Potassium | BP | 50mg | ||||
| Paracetamol | IP | 325mg | ||||
| Serratiopeptidase | IP | 15mg | ||||
| (As 30,000 Enzymatic units of Serratiopeptidase) | q.s | |||||
| Excipients | ||||||
| Colour: Sunset Yellow | ||||||
| 723 | Paracetamol, Levocetirizine Hydrochloride ,Dextromethorphan Hydrobromide,Phenylephrine Hydrochloride & Caffeine Tablets | Each uncoated Tablet Contains: | ||||
| Paracetamol | IP | 325mg | ||||
| Levocetirizine Hydrochloride | IP | 5mg | ||||
| Dextromethorphan Hydrobromide | IP | 5mg | ||||
| Phenylephrine Hydrochloride | IP | 5mg | ||||
| Caffeine Anhydrous | IP | 30mg | ||||
| Excipients | q.s | |||||
| Approved colour used | ||||||
| 724 | Nimesulide, Paracetamol & Serratiopeptidase tablets | Each Film coated tablet Contains: | ||||
| Nimesulide | BP | 100mg | ||||
| Paracetamol | IP | 325mg | ||||
| Serratiopeptidase (Enteric coated) | IP | 15mg | ||||
| (As 30,000 Enzymatic units of Serratiopeptidase) | q.s | |||||
| Excipients | ||||||
| Approved colour used | ||||||
| 725 | nimesulide, Phenylephrine Hydrochloride,Cetirizine dihydrochloride &Caffeine tablets | Each Film coated tablet Contains: | ||||
| Nimesulide | BP | 100mg | ||||
| Phenylephrine Hydrochloride | IP | 10mg | ||||
| Cetrizine dihydrochloride | IP | 5mg | ||||
| Caffeine Anhydrous | IP | 30mg | ||||
| Excipients | q.s | |||||
| Approved colour used | ||||||
| 726 | Aceclofenac,Paracetamol,Cetirizine,Phenylephrine Hydrochloide & CaffeineTablets | Each uncoated Tablet Contains: | ||||
| Aceclofenac | IP | 100mg | ||||
| Paracetamol | IP | 325mg | ||||
| Cetirizine Dihydrochloride | IP | 10mg | ||||
| Phenylephrine Hydrochloride | IP | 5mg | ||||
| Caffeine Anhydrous | IP | 25mg | ||||
| Excipients | q.s | |||||
| Approved colour used | ||||||
| 727 | Paracetamol Levocetirizine Hydrochloride & | Each Film Coated Tablet Contains: | ||||
| Phenylephrine Hydrochloride Tablets | Paracetamol | IP | 325mg | |||
| Cetrizine dihydrochloride | IP | 5mg | ||||
| Phenylephrine Hydrochloride | IP | 10mg | ||||
| Caffeine Anhydrous | IP | 30mg | ||||
| Excipients | Q.S | |||||
| Approved colour used | ||||||
| 728 | Paracetamol,Phenylephrine Hydrochloride,Chlorpheniramine Maleate&Caffeine Tablets | Each Film coated tablet Contains: | ||||
| Paracetamol | IP | 325mg | ||||
| Phenylephrine Hydrochloride | IP | 10mg | ||||
| Chlorpheniramine Maleate | IP | 2mg | ||||
| Caffeine Anhydrous | IP | 30mg | ||||
| Excipients | Q.S | |||||
| Approved colour used | ||||||
| 727 | Paracetamol , Phenylephrine Hydrochloride,Caffeine & Diphenhydramine Hydrochloride Tablets | Each uncoated Tablet Contains: | ||||
| Paracetamol | IP | 500mg | ||||
| Phenylephrine Hydrochloride | IP | 5mg | ||||
| Caffeine Anhydrous | IP | 30mg | ||||
| Diphenhydramine hydrochoride | IP | 25mg | ||||
| Excipients | Q.S | |||||
| Approved colour used | ||||||
| 728 | Tranexamic Acid & Mefenamic Acid Tablets | Each Film coated tablet Contains: | ||||
| Tranexamic Acid | IP | 500mg | ||||
| Mefenamic Acid | IP | 250mg | ||||
| Excipients | Q.S | |||||
| Approved colour used | ||||||
| 729 | Nimesulide,Phenylephrine hydrochloride, Levocetrizine Dihydrochloride Tablets | Each uncoated Tablet Contains: | ||||
| Nimesulide | BP | 100mg | ||||
| Phenylephrine Hydrochloride | IP | 5mg | ||||
| Levocetirizine dihydrochloride | IP | 5mg | ||||
| Excipients | Q.S | |||||
| Approved colour used | ||||||
| 730 | Paracetamol, Phenylephrine Hydrochloride,Guaiphenesin | Each uncoated Tablet Contains: | ||||
| Cetirizine Dihydrochloride & Ambroxol HCl.Tablets | Paracetamol | IP | 325mg | |||
| Phenylephrine Hydrochloride | IP | 5mg | ||||
| Guaiphensin | IP | 50mg | ||||
| Cetrizine dihydrochloride | IP | 5mg | ||||
| Ambroxol Hydrochloride | IP | 15mg | ||||
| Excipients | Q.S | |||||
| Approved colour used | ||||||
| 731 | Glimepiride,pioglitazone & Metformin Hydrochloride Tablets | Each uncoated Tablet Contains: | ||||
| Glimepiride | IP | 1mg | ||||
| Pioglitazone HCl. | IP | 15mg | ||||
| Eq.to Pioglitazone | IP | 500mg | ||||
| Metformin Hydrochloride | Q.S | |||||
| Excipients | ||||||
| Approved colour used | ||||||
| 732 | Glimepiride,pioglitazone & Metformin Hydrochloride Tablets | Each uncoated Tablet Contains: | ||||
| Glimepiride | IP | 2mg | ||||
| Pioglitazone HCl. | IP | 15mg | ||||
| Eq.to Pioglitazone | IP | 500mg | ||||
| Metformin Hydrochloride | Q.S | |||||
| Excipients | ||||||
| Approved colour used | ||||||
| 733 | Cefixime Dispersible Tablets | Each uncoated Dispersible Tablet Contains: | ||||
| Cefixime Trihydrate | IP | 200mg | ||||
| Eq.to Anhydrous Cefixime | Q.S | |||||
| Excipients | ||||||
| Approved colour used | ||||||
| 734 | Cefixime & Lactic acid Bacillus Dispersible Tablets | Each uncoated Dispersible Tablet Contains: | ||||
| Cefixime Trihydrate | IP | 200mg | ||||
| Eq.to Anhydrous Cefixime | ||||||
| Lactic acid Bacillus 60million spores | Q.S | |||||
| Excipients | ||||||
| Approved colour used | ||||||
| 735 | Diclofenac sodium, Paracetamol & Serratiopeptidase | Composition | ||||
| Each Film coated tablets Contains: | ||||||
| Diclofenac sodium | BP | 50mg | ||||
| Paracetamol | IP | 325mg | ||||
| Serratiopeptidase | IP | 10mg | ||||
| (As 20,000 Enzymatic units of Serratiopeptidase) | q.s | |||||
| Excipients | ||||||
| Approved colour used | ||||||
| 736 | Montelukast Sodium & | Each Film coated tablet Contains: | ||||
| Levocetrizine Hydrochloride | Montelukast Sodium | IP | 10mg | |||
| tablets IP | Eq.to Montelukast | IP | 5mg | |||
| Levocetrizine Hydrochloride | Q.S | |||||
| Excipients | ||||||
| colour: Titanium dioxide IP | ||||||
| 737 | Acebrophylline & Acetylcysteine | Each film coated bilayered tablet | ||||
| Tablets | Contains: | 100mg | ||||
| Acebrophylline | BP | 600mg | ||||
| Acetylcysteine | Q.S | |||||
| Excipients | ||||||
| 738 | N-Acetylcysteine Tablets 600mg | Each Uncoated tablet contains: | ||||
| N-Acetylcysteine | BP | 600mg | ||||
| Excipients | Q.S | |||||
| 739 | Levocetirizine HCl.,Montelukast | Each uncoated bilayered tablet | ||||
| & Ambroxol HCl Tablet | contains: | 5mg | ||||
| Levocetrizine Hydrochloride | 10mg | |||||
| Montelukast Sodium | 75mg | |||||
| Eq.to Montelukast | ||||||
| Ambroxol Hydrochloride | q.s | |||||
| (As Sustained release) | ||||||
| Excipients | ||||||
| Approved colour used | IP | |||||
| IP | ||||||
| IP | ||||||
Enquiry